Treacher Collins Syndrome

Mendelian MONDO:0002457 Pathograph 34 Show in embeddings browser Mandibulofacial dysostosis

Treacher Collins syndrome (TCS) is a genetically heterogeneous congenital craniofacial disorder characterized by bilateral and symmetric hypoplasia of the zygomatic bones, maxilla, and mandible, with malar flattening, micrognathia, downslanted palpebral fissures, lower-eyelid abnormalities, external and middle ear anomalies, and conductive hearing loss. Most TCS is autosomal dominant, while biallelic POLR1C or, rarely, POLR1D variants cause autosomal recessive disease. Pathogenic variants in TCOF1, POLR1B, POLR1C, or POLR1D disturb nucleolar function and ribosome biogenesis, activating p53-dependent apoptosis and depleting cranial neural crest cells during embryogenesis. Published prevalence estimates range from approximately 1 in 50,000 to 1 in 80,000, and intellect is typically normal.

Ask OpenScientist

Ask a research question about Treacher Collins Syndrome. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

2
Inheritance
5
Pathophys.
17
Phenotypes
4
Gaps
34
Pathograph
4
Genes
10
Medical Actions
4
Subtypes
5
Differentials
2
Datasets
3
Models
31
References
1
Deep Research
🏷

Classifications

ISDS Skeletal Nosology
dysostoses with predominant craniofacial involvement
👪

Inheritance

2
Autosomal dominant inheritance HP:0000006
Most TCS follows autosomal dominant inheritance with marked variable expressivity. About 55%-61% of autosomal dominant cases are de novo, and each child of an affected individual has a 50% chance of inheriting the pathogenic variant.
Autosomal dominant inheritance
Show evidence (3 references)
PMID:20301704 SUPPORT Other
"Autosomal dominant inheritance accounts for most of TCS, most commonly heterozygous pathogenic variants in TCOF1 and less commonly heterozygous pathogenic variants in POLR1B or POLR1D."
GeneReviews confirms autosomal dominant inheritance as the predominant pattern for TCS.
PMID:20301704 SUPPORT Other
"About 55%-61% of individuals with autosomal dominant TCS have the disorder as the result of a de novo pathogenic variant."
High de novo rate explains sporadic cases.
PMID:20301704 SUPPORT Other
"Each child of an individual with autosomal dominant TCS has a 50% chance of inheriting the pathogenic variant."
GeneReviews provides the recurrence risk for offspring in autosomal dominant TCS.
Autosomal recessive inheritance HP:0000007
A minority of TCS is caused by biallelic pathogenic variants in POLR1C or POLR1D. When both parents are heterozygous, each pregnancy has a 25% chance of an affected child, a 50% chance of a carrier, and a 25% chance of a child who is unaffected and not a carrier.
Autosomal recessive inheritance
Show evidence (2 references)
PMID:20301704 SUPPORT Other
"Autosomal recessive inheritance (biallelic pathogenic variants in POLR1C or POLR1D) accounts for a minority of TCS."
GeneReviews documents the autosomal recessive minority of TCS.
PMID:20301704 SUPPORT Other
"each sib of an individual with autosomal recessive TCS has at conception a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier."
GeneReviews provides the sibling recurrence risks for autosomal recessive TCS.

Subtypes

4
Treacher Collins Syndrome 1 (TCOF1) MONDO:0007944
The most common subtype, caused by heterozygous pathogenic variants in TCOF1 encoding Treacle, a nucleolar phosphoprotein required for ribosomal DNA transcription and ribosome biogenesis.
Show evidence (1 reference)
PMID:34573374 SUPPORT Other
"TCS can be caused by pathogenic variants in the TCOF1, POLR1D, POLR1C and POLR1B genes. Genetically, the TCOF1 gene contains 27 exons which encodes the Treacle protein. In TCOF1, over 200 pathogenic variants have been identified"
Identifies TCOF1 as a causative gene for TCS with over 200 known pathogenic variants.
Treacher Collins Syndrome 2 (POLR1D, AD or rare AR) MONDO:0013385
Caused by heterozygous pathogenic variants in POLR1D or, rarely, by biallelic POLR1D variants. POLR1D encodes a subunit shared by RNA polymerases I and III.
Show evidence (1 reference)
PMID:20301704 SUPPORT Other
"heterozygous pathogenic variant in TCOF1, POLR1D, or POLR1B, biallelic pathogenic variants in POLR1C, or, rarely, biallelic pathogenic variants in POLR1D identified by molecular genetic testing."
GeneReviews lists POLR1D heterozygous variants as a diagnostic criterion for TCS.
Treacher Collins Syndrome 3 (POLR1C, AR) MONDO:0009558
Caused by biallelic pathogenic variants in POLR1C, encoding a subunit shared by RNA polymerases I and III. Autosomal recessive inheritance.
Show evidence (1 reference)
PMID:20301704 SUPPORT Other
"Autosomal recessive inheritance (biallelic pathogenic variants in POLR1C or POLR1D) accounts for a minority of TCS."
GeneReviews confirms biallelic POLR1C variants cause autosomal recessive TCS.
Treacher Collins Syndrome 4 (POLR1B) MONDO:0030067
Caused by heterozygous pathogenic variants in POLR1B, encoding the second largest subunit of RNA polymerase I.
Show evidence (1 reference)
PMID:34573374 SUPPORT Other
"Four subtypes of Treacher Collins syndrome exist. TCS can be caused by pathogenic variants in the TCOF1, POLR1D, POLR1C and POLR1B genes."
Identifies POLR1B as one of the four causative genes defining TCS subtypes.
?

Discussions and Knowledge Gaps

4
Can prenatal reduction of p53 signaling or oxidative stress prevent human TCS malformations without unacceptable developmental, oncogenic, or pregnancy risk?
HUMAN MODEL MISMATCH OPEN prenatal_stress_rescue_translation_gap
Genetic/pharmacologic p53 inhibition and maternal antioxidant treatment can rescue Tcof1+/- mice, and both strategies improve the polr1c-deficient zebrafish phenotype within a narrow embryonic window. The target window in humans precedes or overlaps common recognition of pregnancy, and systemic p53 inhibition interferes with a tumor-suppressor and DNA-damage response. Antioxidant identity, dose, tissue delivery, genotype coverage, and fetal safety are unresolved. These interventions therefore remain mechanistic animal-model probes, not clinical treatments.
Show evidence (3 references)
PMID:18246078 SUPPORT Model Organism
"suppression of p53 function provides an attractive avenue for possible clinical prevention of TCS craniofacial birth defects"
The source itself frames p53 suppression as a possible future avenue rather than established treatment.
PMID:26792133 SUPPORT Model Organism
"maternal antioxidant dietary supplementation may provide an avenue for protection against the pathogenesis of TCS and similar neurocristopathies."
The antioxidant strategy is similarly prospective and based on a prenatal mouse rescue.
PMID:38556235 SUPPORT Model Organism
"inhibiting p53 activation or applying antioxidants within a specific time window, notably within 30 h post-fertilization (hpf), successfully reversed phenotypic effects induced by polr1c MO."
The TCS3 model emphasizes the narrow developmental timing and nonhuman evidence boundary.
Which reported gene-, exon-, and variant-class associations are robust enough to inform prognosis in an individual with TCS?
INTERPRETATION OPEN genotype_phenotype_correlation_interpretation
A deeply phenotyped 146-person cohort found no phenotype-genotype correlation across TCOF1/POLR1D, variant type, or TCOF1 localization, while a later systematic review reported statistical gene/ancestry and recurrent exon-24 deletion associations. Differences in ascertainment, severity scoring, missing data, family clustering, and small non-TCOF1 sample sizes could explain the discrepancy. The entry therefore records variable expressivity but does not use genotype to predict an individual's severity.
Show evidence (3 references)
PMID:25790162 SUPPORT Human Clinical
"Even though TCOF1 and POLR1D were associated with extreme clinical variability, we found no phenotype-genotype correlation."
The 146-person clinical/molecular cohort reports a negative correlation result.
PMID:36203321 SUPPORT Other
"Our result suggested that the higher severity level was likely to be observed in Asian patients harboring TCOF1 variants rather than POLR1."
The later systematic review reports a positive association that requires cautious interpretation.
PMID:36203321 SUPPORT Other
"Moreover, common 5-bp deletions tended to have a higher severity degree in comparison to any variants within exon 24 of TCOF1."
The systematic review also reports a variant-class association that has not yet established individual prognostic utility.
How should long-read DNA/RNA sequencing, prenatal imaging, and facial-image algorithms be incorporated into TCS diagnosis without overextending small, selected, or ancestry-imbalanced datasets?
INTERPRETATION OPEN emerging_diagnostic_adjuncts_and_generalizability
Long-read multi-omics resolved a cryptic intronic TCOF1 insertion in two paternal half-siblings after conventional testing, establishing value for selected unresolved families rather than first-line use. Prenatal imaging plus molecular testing can identify affected fetuses, but mosaicism and variable expressivity prevent reliable severity prediction. A 2026 facial dysmorphology study reported high sensitivity on 127 publicly available images but lower confidence in Asian than White participants; it remains a research adjunct and cannot replace clinical evaluation or molecular confirmation.
Show evidence (3 references)
PMID:41017149 SUPPORT Human Clinical
"Here, we describe two previously undiagnosed paternal half-siblings affected with clinical TCS, and their apparently unaffected father. Diagnostic short-read RNA sequencing) identified aberrant expression of TCOF1 and optical genome mapping detected a large genomic insertion therein."
The family demonstrates diagnostic value after a long unresolved workup but is too small to establish a general first-line strategy.
PMID:41857598 SUPPORT Other
"Prenatal diagnosis of TCS relies on ultrasound detection of craniofacial anomalies and gene testing, but severity prediction remains challenging due to mosaicism and variable expressivity."
The systematic review supports prenatal diagnosis while defining its prognostic limit.
PMID:41817050 SUPPORT Human Clinical
"A total of 127 images of TCS patients were analysed by F2G. A high diagnostic accuracy of 93.7% was obtained. However, F2G was less confident when diagnosing Asians with TCS than White individuals (p < 0.05)."
Performance on selected public images is promising, while the ancestry-dependent confidence and image-source design limit clinical generalization.
Which multisystem associations and neonatal intervention rates should alter routine care, and which reflect EHR coding or tertiary-NICU ascertainment?
INTERPRETATION OPEN multisystem_and_neonatal_ascertainment
A propensity-matched EHR study of 1,114 coded TCS patients found elevated circulatory, otologic, and selected neurologic diagnoses, while a 103-infant multicenter NICU cohort quantified high tracheostomy and gastrostomy use. These studies broaden multisystem and neonatal outcome ascertainment, but neither supplies population penetrance: coding validity and phenotype/genotype resolution constrain the EHR analysis, and NICU referral enriches for severe neonatal disease. The 2024 European consensus therefore supports initial cardiac/vertebral screening and structured feeding, hearing, vision, and airway surveillance without encoding the cohort estimates as universal phenotype frequencies.
Show evidence (4 references)
PMID:37415506 SUPPORT Human Clinical
"Patients with TCS (n = 1,114) and a propensity matched control cohort without TCS (n = 1,114 matched from n = 110,368,585)."
The national-scale EHR design supplies a large matched comparison but depends on coded diagnoses rather than uniformly confirmed molecular TCS.
PMID:37415506 SUPPORT Human Clinical
"The RR of congenital malformations of the circulatory system in patients with TCS was 8.5 (95% CI 4.44-16.28). Patients with TCS also had higher rates of otologic abnormalities including conductive hearing loss (RR 44, 95% CI 24-83) and nervous system disorders including movement disorders (RR..."
The study identifies associations requiring prospective, molecularly resolved validation before causal or penetrance claims.
PMID:40280475 SUPPORT Human Clinical
"We identified 103 infants with TCS and 11 with NS to compare with the micrognathia cohort (n = 4210). Compared with infants with micrognathia, those with TCS were more likely to undergo tracheostomy (54% vs 11%) and gastrostomy tube placement (67% vs 35%) and were less likely to undergo..."
The cohort materially informs severe neonatal planning, but admission to participating NICUs selects for high-acuity infants.
+ 1 more reference

Pathophysiology

5
Impaired Ribosome Biogenesis in Neural Crest Cells
Dominant TCOF1, POLR1B, or POLR1D loss of function and biallelic POLR1C/POLR1D loss of function collectively disrupt one or more RNA polymerase I-associated steps in rRNA transcription, rRNA processing, and production of mature ribosomes. Cranial neural crest and neuroepithelial cells are selectively vulnerable to this nucleolar stress during early craniofacial development.
Migratory neural crest cell CL:0000333 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves Migratory neural crest cell (CL:0000333). CL:0000333 is a cell type from the Cell Ontology.
TCOF1 hgnc:11654 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves TCOF1 (hgnc:11654). hgnc:11654 is a gene from the HUGO Gene Nomenclature Committee. POLR1B hgnc:20454 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves POLR1B (hgnc:20454). hgnc:20454 is a gene from the HUGO Gene Nomenclature Committee. POLR1C hgnc:20194 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves POLR1C (hgnc:20194). hgnc:20194 is a gene from the HUGO Gene Nomenclature Committee. POLR1D hgnc:20422 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves POLR1D (hgnc:20422). hgnc:20422 is a gene from the HUGO Gene Nomenclature Committee.
Ribosome biogenesis GO:0042254 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased Ribosome biogenesis (GO:0042254). GO:0042254 is a biological process from the Gene Ontology. ↓ DECREASED
Pharyngeal arch UBERON:0002539 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in Pharyngeal arch (UBERON:0002539). UBERON:0002539 is an anatomical location from the Uberon multi-species anatomy ontology.
Show evidence (5 references)
PMID:16938878 SUPPORT Model Organism
"Tcof1/Treacle regulates proliferation by controlling the production of mature ribosomes."
The Tcof1 mouse model directly links Treacle dosage to mature-ribosome production.
PMID:29364875 SUPPORT In Vitro
"genetic perturbations associated with Treacher Collins syndrome, a craniofacial disorder caused by heterozygous mutations in components of the Pol I transcriptional machinery or its cofactor TCOF1 (ref. 1), lead to relocalization of DDX21 from the nucleolus to the nucleoplasm, its loss from the..."
Human-cell perturbations show the shared nucleolar and rRNA-processing defect.
PMID:24690222 SUPPORT Other
"The association of the TCOF1 gene product, Treacle, and gene products of POLR1C and POLR1D with ribosome biosynthesis suggests that a loss of function mutation in these genes disrupts ribosome biosynthesis in constituent neural crest cells and neuroepithelium leading to apoptosis."
This review supplies cross-gene context; the primary-model evidence above supports the mechanistic nodes.
+ 2 more references
TCOF1-Associated Oxidative DNA Damage
In TCOF1-associated TCS, reduced Treacle-dependent DNA-damage response and repair increase oxidative DNA damage in the embryonic neuroepithelium. This is a TCOF1-specific parallel input to cell death and should not be assumed for every POLR1B/POLR1C/POLR1D genotype.
Neuroepithelial cell CL:0000710 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves Neuroepithelial cell, annotated with neurecto-epithelial cell (CL:0000710). CL:0000710 is a cell type from the Cell Ontology.
TCOF1 hgnc:11654 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves TCOF1 (hgnc:11654). hgnc:11654 is a gene from the HUGO Gene Nomenclature Committee.
Cellular response to oxidative stress GO:0034599 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal Cellular response to oxidative stress (GO:0034599). GO:0034599 is a biological process from the Gene Ontology. ⚠ ABNORMAL
Neural tube UBERON:0001049 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in Neural tube (UBERON:0001049). UBERON:0001049 is an anatomical location from the Uberon multi-species anatomy ontology.
Show evidence (1 reference)
PMID:26792133 SUPPORT Model Organism
"Tcof1 haploinsufficiency results in oxidative stress-induced DNA damage and neuroepithelial cell death."
The Tcof1 mouse model identifies oxidative DNA damage as a parallel Treacle-dependent mechanism.
p53-Dependent Neuroepithelial Apoptosis
Ribosomal/nucleolar stress, and in TCOF1 deficiency oxidative DNA damage, stabilize p53 and drive excessive apoptosis during the developmental window that generates cranial neural crest cells. Genetic or pharmacologic p53 inhibition rescues craniofacial development in animal models without restoring ribosome biogenesis, supporting apoptosis as a downstream effector rather than p53 inhibition as an established human treatment.
Neuroepithelial cell CL:0000710 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves Neuroepithelial cell, annotated with neurecto-epithelial cell (CL:0000710). CL:0000710 is a cell type from the Cell Ontology.
Apoptotic process GO:0006915 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased Apoptotic process (GO:0006915). GO:0006915 is a biological process from the Gene Ontology. ↑ INCREASED
Neural tube UBERON:0001049 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in Neural tube (UBERON:0001049). UBERON:0001049 is an anatomical location from the Uberon multi-species anatomy ontology.
Show evidence (2 references)
PMID:18246078 SUPPORT Model Organism
"inhibition of p53 prevents cyclin G1-driven apoptotic elimination of neural crest cells while rescuing the craniofacial abnormalities associated with mutations in Tcof1 and extending life span."
Rescue by p53 inhibition establishes the p53-apoptosis effector in Tcof1-deficient embryos.
PMID:38556235 SUPPORT Model Organism
"The pathogenesis of TCS-3 linked to polr1c involves the activation of apoptosis-dependent p53 pathways within neural crest cells (NCCs)."
A POLR1C-deficient zebrafish model extends the p53-apoptosis mechanism beyond TCOF1.
Cranial Neural Crest Cell Deficiency
Reduced formation, proliferation, survival, and migration leave too few cranial neural crest cells to populate the first and second pharyngeal arches. Human TCOF1-haploinsufficient neural crest cells independently show a migration defect, so this node is a population-level developmental state rather than apoptosis itself.
Migratory neural crest cell CL:0000333 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves Migratory neural crest cell (CL:0000333). CL:0000333 is a cell type from the Cell Ontology.
Neural crest cell development GO:0014032 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal Neural crest cell development (GO:0014032). GO:0014032 is a biological process from the Gene Ontology. ⚠ ABNORMAL Neural crest cell migration GO:0001755 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased Neural crest cell migration (GO:0001755). GO:0001755 is a biological process from the Gene Ontology. ↓ DECREASED
Pharyngeal arch UBERON:0002539 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in Pharyngeal arch (UBERON:0002539). UBERON:0002539 is an anatomical location from the Uberon multi-species anatomy ontology.
Show evidence (2 references)
PMID:16938878 SUPPORT Model Organism
"Haploinsufficiency of Tcof1 leads to a deficiency in migrating neural crest cells, which results in severe craniofacial malformations."
The Tcof1 mouse model directly demonstrates the neural crest population deficit.
PMID:30375284 SUPPORT In Vitro
"We also report for the first time an impairment of migration in TCOF1+/- NC and mesenchymal stem cells."
Human TCOF1-haploinsufficient neural crest cells show impaired migration in vitro.
Serial Craniofacial Arch-Derivative Maldevelopment
Deficient cranial neural crest contribution produces a coordinated, typically bilateral malformation bundle across serial first- and second-pharyngeal-arch derivatives: zygoma, maxilla, mandible, external and middle ear, palate, and periocular soft tissues.
Embryonic cranial skeleton morphogenesis GO:0048701 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal Embryonic cranial skeleton morphogenesis (GO:0048701). GO:0048701 is a biological process from the Gene Ontology. ⚠ ABNORMAL
mandible UBERON:0001684 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in mandible (UBERON:0001684). UBERON:0001684 is an anatomical location from the Uberon multi-species anatomy ontology. zygomatic bone UBERON:0001683 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in zygomatic bone, annotated with jugal bone (UBERON:0001683). UBERON:0001683 is an anatomical location from the Uberon multi-species anatomy ontology.
Show evidence (1 reference)
PMID:20301704 SUPPORT Other
"Treacher Collins syndrome (TCS) is characterized by lower eyelid abnormalities, malar hypoplasia, downslanted palpebral fissures, and micro- or retrognathia due to symmetric hypoplasia of the zygomatic bones, maxilla, and mandible."
GeneReviews describes the characteristic bilateral symmetric craniofacial skeletal hypoplasia.

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for Treacher Collins Syndrome Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.

Phenotypes

17
Digestive 1
Feeding Difficulties HP:0011968 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Feeding difficulties (HP:0011968). HP:0011968 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:20301704 SUPPORT Other
"Significant respiratory and feeding difficulties can be present in infancy."
GeneReviews identifies feeding difficulties as a significant neonatal concern.
Ear 2
Conductive Hearing Loss FREQUENT Conductive hearing impairment HP:0000405 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Conductive hearing impairment (HP:0000405). HP:0000405 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:20301704 SUPPORT Other
"About 40%-50% of individuals have conductive hearing loss attributed most commonly to malformation of the ossicles and hypoplasia of the middle ear cavities."
GeneReviews specifies the frequency and mechanism of conductive hearing loss in TCS.
Atresia of External Auditory Canal FREQUENT Atresia of the external auditory canal HP:0000413 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Atresia of the external auditory canal (HP:0000413). HP:0000413 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
"Table 2. continued from previous page. Feature Frequency Atresia of external ear canal Frequent (30%-75%)"
GeneReviews Table 2 places external-auditory-canal atresia in its frequent (30%-75%) feature group.
Eye 1
Strabismus OCCASIONAL HP:0000486 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Strabismus (HP:0000486). HP:0000486 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:35032653 SUPPORT Human Clinical
"Primary ocular anomalies were reported in 98.5% of cases, secondary anomalies in 34.5%, strabismus in 27.3%, refractive errors in 49.5%, and visual impairment in 4.6%."
Strabismus in 27.3% of the 194-person cohort falls in the OCCASIONAL band.
Head and Neck 6
Malar Flattening VERY_FREQUENT HP:0000272 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Malar flattening (HP:0000272). HP:0000272 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
"Table 2. Treacher Collins Syndrome: Frequency of Select Features Feature Frequency Downslanted palpebral fissures Very frequent (>75%) Malar hypoplasia / hypoplasia of zygomatic bones Conductive hearing loss Mandibular hypoplasia w/micro- or retrognathia"
GeneReviews Table 2 places malar hypoplasia in its very-frequent (>75%) feature group, supporting the structured qualitative band.
Micrognathia VERY_FREQUENT HP:0000347 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Micrognathia (HP:0000347). HP:0000347 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
"Table 2. Treacher Collins Syndrome: Frequency of Select Features Feature Frequency Downslanted palpebral fissures Very frequent (>75%) Malar hypoplasia / hypoplasia of zygomatic bones Conductive hearing loss Mandibular hypoplasia w/micro- or retrognathia"
GeneReviews Table 2 places mandibular hypoplasia with micro- or retrognathia in its very-frequent (>75%) feature group.
Downslanted Palpebral Fissures VERY_FREQUENT HP:0000494 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Downslanted palpebral fissures (HP:0000494). HP:0000494 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
"Primary ocular anomalies were described in almost all individuals, mostly consisting of downslanted palpebral fissures (93.8%), colobomata of the lower eyelids (69.6%), and (partial) absence of lower lid eyelashes (42.8%)."
The updated GeneReviews chapter reports downslanted palpebral fissures in 93.8%, within the VERY_FREQUENT band.
Cleft Palate OCCASIONAL HP:0000175 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Cleft palate (HP:0000175). HP:0000175 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
"Delayed speech development Dental anomalies Preauricular hair displacement Cleft palate Less common (10%-30%)"
GeneReviews Table 2 places cleft palate in its less-common (10%-30%) feature group, matching the OCCASIONAL structured band.
Choanal Atresia OCCASIONAL HP:0000453 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Choanal atresia (HP:0000453). HP:0000453 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
"Cleft palate Less common (10%-30%)Choanal stenosis/atresia Cardiac malformation Rachis malformation"
GeneReviews Table 2 places choanal stenosis/atresia in its less-common (10%-30%) feature group, matching the OCCASIONAL structured band.
Dental Anomalies FREQUENT Abnormality of the dentition HP:0000164 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Dental anomalies, annotated with Abnormality of the dentition (HP:0000164). HP:0000164 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
"Atresia of external ear canal Frequent (30%-75%) Microtia Coloboma (notching) of lower lid Delayed speech development Dental anomalies"
GeneReviews Table 2 places dental anomalies in its frequent (30%-75%) feature group.
Nervous System 2
Obstructive Sleep Apnea HP:0002870 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Obstructive sleep apnea (HP:0002870). HP:0002870 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:20301704 SUPPORT Other
"assess for manifestations of obstructive sleep apnea, growth, and caloric intake at each visit"
GeneReviews surveillance recommendations include assessment for OSA at each visit.
Delayed Speech and Language Development FREQUENT HP:0000750 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Delayed speech and language development (HP:0000750). HP:0000750 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
"Atresia of external ear canal Frequent (30%-75%) Microtia Coloboma (notching) of lower lid Delayed speech development"
GeneReviews Table 2 places delayed speech development in its frequent (30%-75%) feature group.
Respiratory 1
Upper Airway Obstruction HP:0002781 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Upper airway obstruction (HP:0002781). HP:0002781 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:20301704 SUPPORT Other
"Neonates with airway issues may require airway management at delivery, special positioning, or tracheostomy to facilitate ventilation."
GeneReviews describes significant airway obstruction requiring intervention in some neonates.
Other 4
Microtia FREQUENT HP:0008551 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Microtia (HP:0008551). HP:0008551 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
"Table 2. continued from previous page. Feature Frequency Atresia of external ear canal Frequent (30%-75%) Microtia"
GeneReviews Table 2 places microtia in its frequent (30%-75%) feature group.
Lower Eyelid Coloboma FREQUENT HP:0000652 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Lower eyelid coloboma (HP:0000652). HP:0000652 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
"Primary ocular anomalies were described in almost all individuals, mostly consisting of downslanted palpebral fissures (93.8%), colobomata of the lower eyelids (69.6%), and (partial) absence of lower lid eyelashes (42.8%)."
The updated GeneReviews chapter reports lower-eyelid colobomata in 69.6%, within the FREQUENT band.
Sparse Lower Eyelid Eyelashes FREQUENT Sparse lower eyelashes HP:0007776 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Sparse lower eyelashes (HP:0007776). HP:0007776 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
"Primary ocular anomalies were described in almost all individuals, mostly consisting of downslanted palpebral fissures (93.8%), colobomata of the lower eyelids (69.6%), and (partial) absence of lower lid eyelashes (42.8%)."
The updated GeneReviews chapter reports absent lower-lid eyelashes in 42.8%, within the FREQUENT band.
Abnormality of Refraction FREQUENT HP:0000539 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Abnormality of refraction (HP:0000539). HP:0000539 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:35032653 SUPPORT Human Clinical
"Primary ocular anomalies were reported in 98.5% of cases, secondary anomalies in 34.5%, strabismus in 27.3%, refractive errors in 49.5%, and visual impairment in 4.6%."
Refractive errors in 49.5% of the cohort fall in the FREQUENT band.
🧬

Genetic Associations

4
TCOF1
Gene: TCOF1 hgnc:11654 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is TCOF1 (hgnc:11654). hgnc:11654 is a gene from the HUGO Gene Nomenclature Committee. relationship_type: CAUSATIVE
Autosomal dominant
Show evidence (4 references)
PMID:34573374 SUPPORT Other
"the TCOF1 gene contains 27 exons which encodes the Treacle protein. In TCOF1, over 200 pathogenic variants have been identified, of which most are deletions leading to a frame-shift, that result in the formation of a termination codon."
Details the molecular genetics of TCOF1 mutations in TCS.
PMID:33804586 SUPPORT Other
"One of the crucial proteins involved in most of the key nucleolar functions is treacle phosphoprotein encoded by the TCOF1 gene."
Identifies Treacle as a key nucleolar protein central to ribosome biogenesis.
PMID:39920764 SUPPORT Human Clinical
"We identified 11 mutations predominantly localized to the central repeat domain (CRD) and the C-terminal domain (CTD, including the nuclear localization sequence) of TCOF1."
A 2025 Chinese cohort expands the observed TCOF1 variant spectrum without supplying a universal gene-attribution percentage.
+ 1 more reference
POLR1D
Gene: POLR1D hgnc:20422 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is POLR1D (hgnc:20422). hgnc:20422 is a gene from the HUGO Gene Nomenclature Committee. relationship_type: CAUSATIVE
Autosomal dominant Autosomal recessive
Show evidence (1 reference)
PMID:34573374 SUPPORT Other
"TCS can be caused by pathogenic variants in the TCOF1, POLR1D, POLR1C and POLR1B genes."
Lists POLR1D as a causative gene for TCS.
POLR1C
Gene: POLR1C hgnc:20194 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is POLR1C (hgnc:20194). hgnc:20194 is a gene from the HUGO Gene Nomenclature Committee. relationship_type: CAUSATIVE
Autosomal recessive
Show evidence (1 reference)
PMID:34573374 SUPPORT Other
"TCS can be caused by pathogenic variants in the TCOF1, POLR1D, POLR1C and POLR1B genes."
Lists POLR1C as a causative gene for TCS.
POLR1B
Gene: POLR1B hgnc:20454 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is POLR1B (hgnc:20454). hgnc:20454 is a gene from the HUGO Gene Nomenclature Committee. relationship_type: CAUSATIVE
Autosomal dominant
Show evidence (1 reference)
PMID:20301704 SUPPORT Other
"a heterozygous pathogenic variant in TCOF1, POLR1D, or POLR1B, biallelic pathogenic variants in POLR1C"
GeneReviews lists POLR1B as a TCS-causing gene.
💊

Medical Actions

10
Craniofacial Reconstruction
Action: craniofacial surgical procedureNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is craniofacial surgical procedure, annotated with Surgical Procedure (NCIT:C15329). NCIT:C15329 is a clinical intervention from the NCI Thesaurus. Ontology label: Surgical Procedure NCIT:C15329
Zygomatic, orbital, and mandibular reconstruction is planned by a multidisciplinary team and individualized to anatomy, function, severity, and likely reoperation burden. When breathing is not a concern, final orthognathic surgery is preferably deferred until skeletal maturity; earlier functional intervention may be required for airway, feeding, eyelid-closure, speech, or hearing problems.
Show evidence (3 references)
PMID:20301704 SUPPORT Other
"Craniofacial reconstruction is often necessary: zygomatic and orbital reconstruction at about age five to seven years, and bilateral microtia and/or narrow ear canal reconstruction after age six years."
GeneReviews supplies commonly used age windows, which are contextualized rather than treated as universal by the newer consensus.
PMID:38801252 SUPPORT Other
"The optimal timing and sequence of craniofacial reconstruction procedures should be individualized based on the severity of the craniofacial anomalies and functional problems, including mouth opening, speech, feeding, (sleep related) breathing, closure of the eyelids, and hearing."
European expert consensus makes severity and function, rather than age alone, the basis for sequencing reconstruction.
PMID:38801252 SUPPORT Other
"However, in cases where breathing issues is not of concern, it is preferred to carry out (final) orthognathic surgery once the patient reaches skeletal maturity to avoid unnecessary reoperation."
The consensus corrects the older unqualified pre-age-16 framing for final orthognathic surgery.
Speech Therapy
Action: speech therapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is speech therapy, annotated with Speech Language Therapy (NCIT:C159273). NCIT:C159273 is a clinical intervention from the NCI Thesaurus. Ontology label: Speech Language Therapy NCIT:C159273
Speech and language therapy for developmental delay associated with conductive hearing impairment.
Target Phenotypes: Delayed speech and language development HP:0000750 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Delayed speech and language development (HP:0000750). HP:0000750 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:20301704 SUPPORT Other
"Hearing loss is treated with bone conduction amplification, speech therapy, and educational intervention."
GeneReviews explicitly includes speech therapy within the multimodal approach to conductive hearing loss.
Airway Management
Airway care spans neonatal positioning, intubation or tracheostomy when required, routine obstructive-sleep-apnea screening with polysomnography, multilevel airway evaluation before intervention, and a documented perioperative difficult-airway plan. Intervention is individualized to the site and severity of obstruction.
Target Phenotypes: Upper airway obstruction HP:0002781 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Upper airway obstruction (HP:0002781). HP:0002781 is a phenotype from the Human Phenotype Ontology.
Show evidence (4 references)
PMID:20301704 SUPPORT Other
"Neonates with airway issues may require airway management at delivery, special positioning, or tracheostomy to facilitate ventilation."
GeneReviews describes airway management strategies.
PMID:40280475 SUPPORT Human Clinical
"Compared with infants with micrognathia, those with TCS were more likely to undergo tracheostomy (54% vs 11%) and gastrostomy tube placement (67% vs 35%) and were less likely to undergo mandibular distraction (9.7% vs 28.2%)."
A 103-infant TCS NICU cohort quantifies major neonatal airway and feeding interventions; the selected NICU denominator is not a population frequency.
PMID:37646339 SUPPORT Human Clinical
"This study found a positive correlation between severity of maxillomandibular dysmorphology and perioperative airway difficulty in TCS patients."
The 222-procedure cohort supports severity-stratified perioperative airway planning across the lifespan.
+ 1 more reference
Enteral Tube Feeding
Action: Enteral Tube FeedingNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Enteral Tube Feeding (NCIT:C93322). NCIT:C93322 is a clinical intervention from the NCI Thesaurus. NCIT:C93322
Nasogastric or gastrostomy feeding can protect the airway and maintain caloric intake when mandibular, palatal, or swallowing abnormalities prevent safe and adequate oral feeding.
Target Phenotypes: Feeding difficulties HP:0011968 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Feeding difficulties (HP:0011968). HP:0011968 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
"Assess nutrition and feeding support including nasogastric or gastrostomy tube feedings as needed to assure adequate caloric intake while protecting the airway"
GeneReviews recommends enteral feeding when oral intake is unsafe or inadequate.
PMID:40280475 SUPPORT Human Clinical
"Compared with infants with micrognathia, those with TCS were more likely to undergo tracheostomy (54% vs 11%) and gastrostomy tube placement (67% vs 35%) and were less likely to undergo mandibular distraction (9.7% vs 28.2%)."
The multicenter NICU cohort documents frequent gastrostomy use among critically affected neonates without generalizing 67% to all TCS.
Cleft Palate Repair
Action: PalatorrhaphyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Palatorrhaphy (NCIT:C168380). NCIT:C168380 is a clinical intervention from the NCI Thesaurus. NCIT:C168380
Cleft-palate repair is considered only after airway assessment. European consensus supports repair when obstructive AHI is 5 or lower without significant carbon-dioxide retention, or when polysomnography is normal, with high-care postoperative respiratory monitoring. Timing is individualized because reliable comparative timing and outcome evidence in facial dysostosis remains lacking.
Target Phenotypes: Cleft palate HP:0000175 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Cleft palate (HP:0000175). HP:0000175 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:38801252 SUPPORT Other
"If a cleft palate is (also) present, its repair can be considered if the obstructive apnea-hypopnea index (AHI) is ≤5 and there is no significant carbon dioxide retention or polysomnography results with or without a custom-made palatal plate are normal."
The European consensus supplies the airway-safety qualification missing from an age-only repair recommendation.
PMID:38801252 SUPPORT Other
"Similarly, evidence on the relative effectiveness of different surgical approaches for palate repair in FDS patients, including different timing, is also lacking."
This explicitly limits confidence in any universal age or technique.
Hearing Amplification
Audiology-directed amplification should start early. Air-conduction devices are the first choice when outer-ear anatomy permits and hearing and speech outcomes are acceptable; bone-conduction devices are an alternative for conductive or mixed loss from outer- or middle-ear malformation. Noninvasive versus implanted systems are individualized to anatomy, age, hearing loss, expected benefit, and patient preferences, and bone-conduction rehabilitation is preferred over reconstructive canal or middle-ear surgery when those surgical outcomes are expected to be poor.
Target Phenotypes: Conductive hearing impairment HP:0000405 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Conductive hearing impairment (HP:0000405). HP:0000405 is a phenotype from the Human Phenotype Ontology.
Show evidence (6 references)
PMID:38801252 SUPPORT Other
"the experts came to an agreement that air-conducting hearing devices are an appropriate first choice in FDS patients if acceptable hearing and speech intelligibility can be achieved, and their outer ear anatomy allows for wearing them"
The European consensus establishes the conditional first-line role of air-conduction amplification.
PMID:38801252 SUPPORT Other
"For FDS patients with malformations of the middle and/or outer ears resulting in conductive or mixed hearing loss, bone-anchored or bone-conducting hearing devices are appropriate alternatives"
The consensus defines the anatomy and hearing-loss context in which bone-conduction devices are appropriate.
PMID:38248782 SUPPORT Other
"In all other studies, it was evident that both conventional hearing aids and the various bone conduction devices improved auditory capacity by an average of about 30 dB."
The 2024 systematic review summarizes objective improvement while noting small cohorts.
+ 3 more references
Periocular and Eyelid Reconstruction
Action: Ophthalmologic Surgical ProcedureNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Ophthalmologic Surgical Procedure (NCIT:C15331). NCIT:C15331 is a clinical intervention from the NCI Thesaurus. NCIT:C15331
Perinatal ophthalmology assessment identifies vision risk from lower-eyelid coloboma, corneal exposure, refractive error, and strabismus. Lubrication is sufficient for many colobomas, but lesions threatening corneal integrity should be repaired in infancy; otherwise eyelid reconstruction is individualized to function and anatomy.
Target Phenotypes: Lower eyelid coloboma HP:0000652 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Lower eyelid coloboma (HP:0000652). HP:0000652 is a phenotype from the Human Phenotype Ontology. Downslanted palpebral fissures HP:0000494 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Downslanted palpebral fissures (HP:0000494). HP:0000494 is a phenotype from the Human Phenotype Ontology.
Show evidence (3 references)
PMID:38857421 SUPPORT Human Clinical
"Among 50 subjects, the mean follow-up was 10.5 ± 5.9 years. Periorbital findings included downslanting palpebral fissures (100%), eyelash deficiency (70%), eyelid coloboma (54%), and significant refractive error (50%)."
The modern pediatric cohort defines the clinical burden informing perinatal risk assessment.
PMID:38857421 SUPPORT Human Clinical
"Alhough most eyelid colobomas can be managed with lubrication, those threatening corneal integrity should be repaired in infancy."
This directly supports conservative management for most colobomas and early repair when the cornea is threatened; the misspelling is reproduced from the indexed abstract.
PMID:38801252 SUPPORT Other
"in FDS patients with eyelid abnormalities without functional consequences, there is no critical timing for reconstructive eyelid surgery"
European consensus supports individualized timing when vision and corneal integrity are not threatened.
Orthodontic Management
Longitudinal orthodontic monitoring addresses growth and development of the dentition and jaws within lifelong multidisciplinary dental care.
Target Phenotypes: Dental anomalies HP:0000164 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Dental anomalies, annotated with Abnormality of the dentition (HP:0000164). HP:0000164 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
"Misaligned teeth often require orthodonture."
GeneReviews explicitly recommends orthodonture for tooth misalignment.
PMID:38801252 SUPPORT Other
"recommended that an orthodontist from the multidisciplinary team monitors the growth and development of the dentition and jaws"
European consensus defines the longitudinal developmental role of the orthodontist.
Multidisciplinary Surveillance
Action: Clinical EvaluationNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Clinical Evaluation (NCIT:C124351). NCIT:C124351 is a clinical intervention from the NCI Thesaurus. NCIT:C124351
Surveillance includes early and longitudinal ophthalmology and audiology, routine obstructive-sleep-apnea screening with polysomnography when indicated, growth and feeding/aspiration assessment, dental review every six months with orthodontic follow-up, and periodic speech and educational assessment. Newly diagnosed patients also receive cardiac and vertebral screening because clinically important extracranial anomalies occur.
Show evidence (5 references)
"Annual ophthalmology and audiology evaluations; assess for manifestations of obstructive sleep apnea, growth, and caloric intake at each visit; dental exams every six months with orthodontia exams as needed; assess speech development and educational progress annually or as needed."
The current GeneReviews chapter supplies an interval-specific surveillance plan.
PMID:38801252 SUPPORT Other
"The experts came to an agreement regarding the importance of ophthalmologic screening in newly diagnosed FDS patients to prevent secondary anomalies and vision impairment."
European consensus supports ophthalmologic screening at diagnosis in addition to longitudinal review.
PMID:38801252 SUPPORT Other
"the experts collectively expressed the necessity of audiological screening soon after birth to allow for timely treatment of hearing loss in FDS patients"
The consensus supplies the early-life audiology component.
+ 2 more references
Genetic Counseling
Category: Counseling / Informational Action: Genetic CounselingNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Genetic Counseling (NCIT:C15240). NCIT:C15240 is a clinical intervention from the NCI Thesaurus. NCIT:C15240
Genetic counseling addresses dominant and recessive inheritance, de novo variation, recurrence risk including parental somatic or germline mosaicism, and prenatal or preimplantation testing. A molecular diagnosis can establish fetal status but cannot reliably predict individual severity.
Show evidence (2 references)
PMID:20301704 SUPPORT Other
"Once the TCS-related pathogenic variant(s) have been identified in an affected family member, prenatal and preimplantation genetic testing are possible."
GeneReviews describes genetic testing and counseling options.
PMID:41857598 SUPPORT Other
"Prenatal diagnosis of TCS relies on ultrasound detection of craniofacial anomalies and gene testing, but severity prediction remains challenging due to mosaicism and variable expressivity. Low-level parental mosaicism materially affects recurrence-risk counselling and should be actively..."
The 2026 systematic review and two-family report supports the mosaicism and severity-prediction caveats in counseling.
🔬

Diagnosis

3
Clinical diagnosis
No consensus clinical diagnostic criteria have been published. A clinical diagnosis can be made from the characteristic bilaterally symmetric facial and mandibular abnormalities, downslanted palpebral fissures, zygomatic and mandibular hypoplasia, and conductive hearing loss. Limb anomalies, microcephaly, or intellectual disability are unusual and should trigger a broader differential diagnosis.
Clinical Evaluation NCIT:C124351 NCI Thesaurus (NCIT)
Results: A compatible symmetric craniofacial and conductive-hearing-loss pattern supports TCS but does not determine the causal gene.
Show evidence (2 references)
"No consensus clinical diagnostic criteria for Treacher Collins syndrome (TCS) have been published."
The current GeneReviews chapter explicitly limits the status of formal clinical criteria.
PMID:20301704 SUPPORT Other
"Treacher Collins syndrome (TCS) is characterized by lower eyelid abnormalities, malar hypoplasia, downslanted palpebral fissures, and micro- or retrognathia due to symmetric hypoplasia of the zygomatic bones, maxilla, and mandible."
GeneReviews describes the characteristic clinical pattern; it does not label it a consensus criterion set.
Molecular genetic testing
Use a craniofacial-disorder multigene panel with sequencing and deletion/duplication analysis, or exome/genome testing when the phenotype is atypical or panel testing is nondiagnostic. The molecular diagnosis is established by a heterozygous pathogenic variant in TCOF1, POLR1B, or POLR1D; biallelic pathogenic variants in POLR1C; or, rarely, biallelic pathogenic variants in POLR1D. A 5q deletion including TCOF1 is another uncommon mechanism. In unresolved cases with strong clinical suspicion, selected structural-variant, RNA, or long-read genomic analyses can reveal cryptic variants missed by routine short-read testing, but these remain complementary rather than first-line tests.
genetic testing NCIT:C15709 NCI Thesaurus (NCIT)
Results: Identification of a genotype matching one of the established dominant or recessive TCS mechanisms establishes the molecular diagnosis.
Show evidence (4 references)
PMID:20301704 SUPPORT Other
"The diagnosis of TCS is established in a proband with characteristic clinical features and/or a heterozygous pathogenic variant in TCOF1, POLR1D, or POLR1B, biallelic pathogenic variants in POLR1C, or, rarely, biallelic pathogenic variants in POLR1D identified by molecular genetic testing."
GeneReviews specifies the molecular diagnostic criteria for TCS.
PMID:25790162 SUPPORT Human Clinical
"Among the atypical negative patients (with intellectual disability and/or microcephaly), we identified four patients carrying a mutation in EFTUD2 and two patients with 5q32 deletion encompassing TCOF1 and CAMK2A in particular."
The 146-person clinical/molecular series documents 5q32 deletions encompassing TCOF1 while also showing why additional features broaden the differential.
PMID:38801252 SUPPORT Other
"Overall, targeted genetic analyses are preferred in patients with a phenotype strongly suggesting a specific FDS, and broader genetic analyses (eg, whole exome or genome sequencing) in those with atypical phenotypes (113) and in those left without genetic confirmation with older genetic analyses."
The European consensus supplies a complete, phenotype-stratified testing recommendation.
+ 1 more reference
Craniofacial and Temporal-Bone CT
Craniofacial CT defines zygomatic and mandibular anatomy for surgical planning. In infants with conductive hearing loss, axial and coronal CT can assess the external canal, middle-ear ossicles and cavity, inner ear, head, and neck anatomy.
Computed Tomography NCIT:C17204 NCI Thesaurus (NCIT)
Results: Typical findings include zygomatic-arch hypoplasia or aplasia, mandibular retrognathia, canal atresia/stenosis, and middle-ear malformation.
Show evidence (2 references)
"In those w/conductive hearing loss identified at age <6 mos: craniofacial CT scan (axial & coronal slices) to assess anatomy of head & neck, external auditory canal, middle ear, & inner ear"
GeneReviews Table 4 provides the complete age, indication, acquisition planes, and anatomic scope of the recommended CT evaluation.
PMID:34573374 SUPPORT Other
"Of significant importance is (computed tomography) CT scanning, used to document the anatomy of the head in order to prepare a plan for surgery, to recognize defects of hearing organs as well as to document progress in different stages of treatment"
This clinical review supports the craniofacial surgical-planning role and hearing-organ assessment.
📊

Prevalence

1
Worldwide
Birth Prevalence 2.0 per 100,000 1–9 per 100,000
Published estimates differ: the 2021 review cites approximately 1 in 50,000 live births (2 per 100,000), while the 2024 GeneReviews update cites an estimated prevalence of 1 in 80,000. The structured value retains the directly stated birth-frequency estimate and should not be read as precise.
Show evidence (2 references)
PMID:34573374 SUPPORT Other
"TCS occurs in the general population at a frequency of 1 in 50,000 live births."
Directly states the prevalence of TCS.
"The prevalence of TCS is estimated at 1:80,000"
The current GeneReviews estimate documents uncertainty around the older 1:50,000 birth-frequency figure.
🔀

Differential Diagnoses

5

Conditions with similar clinical presentations that must be differentiated from Treacher Collins Syndrome:

Overlapping Features SF3B4-related Nager syndrome shares mandibulofacial dysostosis, micrognathia, and downslanted palpebral fissures.
Distinguishing Features
  • Preaxial radial-ray abnormalities such as hypoplastic or absent thumbs, triphalangeal thumbs, radial hypoplasia/aplasia, or radioulnar synostosis favor Nager syndrome; limb anomalies are rare in TCS.
Show evidence (1 reference)
"SF3B4 Acrofacial dysostosis, SF3B4-related (Nager syndrome) (OMIM 154400) AD Downslanted palpebral fissures Micrognathia Mandibulofacial dysostosis Limb deformities Preaxial abnormalities (e.g., small or absent thumbs, triphalangeal thumbs, radial hypoplasia or aplasia, radioulnar synostosis)"
The GeneReviews differential table explicitly associates the preaxial limb pattern with SF3B4-related Nager syndrome.
Miller Syndrome Not Yet Curated MONDO:0009903
Overlapping Features DHODH-related Miller syndrome overlaps through mandibulofacial dysostosis, eyelid coloboma, micrognathia, and cleft lip/palate.
Distinguishing Features
  • Postaxial limb abnormalities, especially small or absent fifth digits/metacarpals, ulnar hypoplasia, or absent fifth toes, favor Miller syndrome.
Show evidence (1 reference)
"DHODH Postaxial acrofacial dysostosis, DHODH-related (Miller syndrome) (OMIM 263750) AR Mandibulofacial dysostosis Eyelid coloboma Micrognathia Cleft lip/palate Limb deformities Postaxial abnormalities (e.g., small or absent 5th digit incl 5th metacarpal, ulnar hypoplasia, absent 5th toe)"
The GeneReviews differential table explicitly associates the postaxial limb pattern with DHODH-related Miller syndrome, bound here to the exact MONDO postaxial acrofacial dysostosis concept.
Overlapping Features EFTUD2-related disease shares mandibulofacial dysostosis, microtia, preauricular tags, cleft palate, and airway involvement.
Distinguishing Features
  • Congenital or progressive microcephaly and intellectual disability are typical, whereas intellect is usually normal in TCS.
  • Facial asymmetry, esophageal atresia/tracheoesophageal fistula, and thumb abnormalities further favor EFTUD2-related disease.
Show evidence (1 reference)
"EFTUD2 Mandibulofacial dysostosis w/ microcephaly, EFTUD2-related (Guion-Almeida type) AD Mandibulofacial dysostosis Microtia Preauricular skin tags Microcephaly is present in most affected persons. Intellectual disability Asymmetry of facial features"
The GeneReviews differential table explicitly links microcephaly, intellectual disability, and asymmetry to EFTUD2-related mandibulofacial dysostosis.
Overlapping Features Craniofacial microsomia can share mandibular/maxillary hypoplasia, microtia, ear-canal atresia, preauricular tags, and clefting.
Distinguishing Features
  • Craniofacial microsomia is usually unilateral or bilaterally asymmetric rather than the characteristic bilateral symmetry of TCS.
  • Epibulbar dermoids and vertebral anomalies, including Klippel-Feil anomaly, favor the craniofacial microsomia/Goldenhar spectrum.
Show evidence (1 reference)
"FOXI3 1 SF3B2 2 Hemifacial microsomia (Goldenhar syndrome, Oculo- auriculo-vertebral spectrum) (OMIM PS164210) AD AR Mandibulofacial dysostosis Microtia Preauricular skin tags Cleft lip/palate Asymmetric Ocular epibulbar dermoid cyst Vertebral anomalies, Klippel-Feil anomaly"
The GeneReviews differential table explicitly links asymmetry, epibulbar dermoid, and vertebral anomalies to hemifacial microsomia.
📊

Related Datasets

2
Microarray Analysis of Treacher Collins Syndrome geo:GSE10167
Whole-embryo expression profiling of three E8.5 Tcof1+/- mouse embryos and three wild-type littermates, generated to identify transcriptional changes associated with Tcof1 haploinsufficiency.
mouse MICROARRAY n=6 Affymetrix GeneChip Mouse Genome 430...
Conditions: E8.5 Tcof1+/- littermate embryo E8.5 wild-type littermate embryo
PMID:18246078
Direct disease-model dataset linked to the p53-rescue study. Because RNA is from whole embryos rather than isolated cranial neural crest, cell-type specificity cannot be inferred directly from this dataset alone.
Show evidence (1 reference)
"Total RNA was extracted from 3 E8.5 wild-type and 3 E8.5 Tcof1+/- littermate embryos"
The GEO record verifies the genotype groups, developmental stage, and sample count.
Surveillance of rRNA synthesis by an RNA helicase mediates tissue-specific developmental disorders geo:GSE89420
Ten human HeLa samples profiling DDX21/TCOF1 chromatin occupancy and DDX21 RNA binding under TCOF1 knockdown, RNA polymerase I inhibition, or actinomycin D treatment.
human MULTI OMICS PERTURBATION n=10 ChIP-seq and DDX21 irCLIP
Conditions: siTCOF1 and control HeLa chromatin profiling RNA polymerase I inhibition and control actinomycin D and DMSO DDX21 irCLIP
PMID:29364875
Mechanistically relevant but not a patient-derived or cranial-neural-crest dataset: all deposited samples are HeLa perturbation experiments. It can support TCOF1/DDX21 nucleolar-stress analysis but cannot establish a disease-specific human craniofacial expression signature. Gene-only cancer datasets returned by discovery were excluded.
Show evidence (3 references)
"HeLa DDX21 ChIP-seq in siTCOF1"
The GEO record verifies the TCOF1-knockdown DDX21 chromatin-profiling sample in HeLa cells.
"HeLa DDX21 ChIP-seq in iPol I treated cells"
The GEO sample list independently verifies the RNA-polymerase-I-inhibition chromatin-profiling arm.
"DDX21 irCLIP from HeLa with ActD Biological replicate 1"
The GEO sample list verifies the DDX21 RNA-binding arm under actinomycin-D treatment in HeLa cells.
🧫

Experimental Models

1
TCOF1-Haploinsufficient Human Pluripotent Stem Cell-Derived Neural Crest Model OTHER
This human developmental cell model complements the mouse studies by reproducing neural crest phenotypes in TCOF1-haploinsufficient cells. It captures cell-autonomous migration and survival behavior but not pharyngeal arch anatomy, tissue interactions, or the full craniofacial phenotype.
Migratory cranial neural crest cell CL:0000008 Cell Ontology (CL) Relation: this experimental model uses this cell type This experimental model uses Migratory cranial neural crest cell (CL:0000008). CL:0000008 is a cell type from the Cell Ontology.
Organism
human NCBITaxon:9606 NCBI Taxonomy (NCBITaxon) Relation: this experimental model is built in this organism This experimental model is built in human, annotated with Homo sapiens (NCBITaxon:9606). NCBITaxon:9606 is an organism from the NCBI Taxonomy.
Cell source
CRISPR/Cas9-engineered TCOF1+/- human pluripotent stem cell lines and separate siRNA TCOF1-knockdown cultures
Culture
Chemically defined neural crest differentiation followed by serial-passage purification and migration assays
Publication
Findings
TCOF1+/- human neural crest cells recapitulate the abnormal cell-death phenotype of the murine TCS model and add a migration deficit.
"The NC cells derived from TCOF1+/- HPSC recapitulate the phenotype of the reported TCS murine model. We also report for the first time an impairment of migration in TCOF1+/- NC and mesenchymal stem cells."
Show evidence (1 reference)
PMID:30375284 SUPPORT In Vitro
"The NC cells derived from TCOF1+/- HPSC recapitulate the phenotype of the reported TCS murine model. We also report for the first time an impairment of migration in TCOF1+/- NC and mesenchymal stem cells."
The finding is stated directly in the model paper.
Show evidence (1 reference)
PMID:30375284 SUPPORT In Vitro
"We assessed the potential of the derived NC population to model the neurocristopathy, Treacher Collins Syndrome (TCS), using small interfering RNA (siRNA) knockdown of TCOF1 and by creating different TCOF1+/- HPSC lines through CRISPR/Cas9 technology."
The primary study describes both perturbation strategies used to construct the human model.
🐁

Animal Models

2
Tcof1 haploinsufficient (Tcof1+/-) Mus musculus
Germline Tcof1 haploinsufficiency is the foundational TCS model. It reproduces deficient mature-ribosome production, p53-dependent neuroepithelial/neural crest apoptosis, neural crest deficiency, and craniofacial hypoplasia. Phenotypic severity depends strongly on strain background, and rescue by p53 inhibition or maternal antioxidants is prenatal animal-model evidence rather than an established human intervention.
Deficient generation and proliferation of migrating cranial neural crest cells Bilateral craniofacial skeletal hypoplasia with perinatal respiratory compromise on susceptible backgrounds
Species
Mus musculus
Genotype
Tcof1 haploinsufficient (Tcof1+/-)
Genes
TCOF1 hgnc:11654 HUGO Gene Nomenclature Committee (hgnc) Relation: this experimental model concerns this gene This experimental model concerns TCOF1 (hgnc:11654). hgnc:11654 is a gene from the HUGO Gene Nomenclature Committee.
Show evidence (3 references)
PMID:16938878 SUPPORT Model Organism
"To investigate the developmental basis of TCS we generated a mouse model through germ-line mutation of Tcof1."
The primary study defines the germline Tcof1 model and its developmental purpose.
PMID:18246078 SUPPORT Model Organism
"inhibition of p53 prevents cyclin G1-driven apoptotic elimination of neural crest cells while rescuing the craniofacial abnormalities associated with mutations in Tcof1 and extending life span."
The rescue experiment validates the p53-dependent component of the mouse model.
PMID:26792133 SUPPORT Model Organism
"maternal treatment with antioxidants minimizes cell death in the neuroepithelium and substantially ameliorates or prevents the pathogenesis of craniofacial anomalies in Tcof1(+/-) mice."
A distinct prenatal rescue supports the oxidative-stress arm in this genotype.
polr1c-deficient TCS3 morpholino model Danio rerio
Transient polr1c deficiency models TCS3 with excess facial-region reactive oxygen species, p53-dependent apoptosis, altered neural crest distribution, and craniofacial cartilage deformity. Morpholino transience and zebrafish anatomy limit direct fidelity to biallelic human POLR1C disease.
Abnormal migrated cranial neural crest distribution in the pharyngeal arches Ethmoid plate craniofacial cartilage deformity
Species
Danio rerio
Genotype
polr1c-deficient TCS3 morpholino model
Genes
POLR1C hgnc:20194 HUGO Gene Nomenclature Committee (hgnc) Relation: this experimental model concerns this gene This experimental model concerns POLR1C (hgnc:20194). hgnc:20194 is a gene from the HUGO Gene Nomenclature Committee.
Show evidence (1 reference)
PMID:38556235 SUPPORT Model Organism
"the restoration of polr1c expression in early embryogenesis effectively rescues the observed craniofacial phenotype in polr1c-deficient zebrafish."
Genetic rescue supports specificity of the polr1c-deficient phenotype.
{ }

Source YAML

click to show
name: Treacher Collins Syndrome
creation_date: '2026-05-28T12:00:00Z'
synonyms:
- Mandibulofacial dysostosis without limb anomalies
- Franceschetti-Klein syndrome
- TCS
description: >-
  Treacher Collins syndrome (TCS) is a genetically heterogeneous congenital
  craniofacial disorder characterized by bilateral and symmetric hypoplasia of
  the zygomatic bones, maxilla, and mandible, with malar flattening,
  micrognathia, downslanted palpebral fissures, lower-eyelid abnormalities,
  external and middle ear anomalies, and conductive hearing loss. Most TCS is
  autosomal dominant, while biallelic POLR1C or, rarely, POLR1D variants cause
  autosomal recessive disease. Pathogenic variants in TCOF1, POLR1B, POLR1C,
  or POLR1D disturb nucleolar function and ribosome biogenesis, activating
  p53-dependent apoptosis and depleting cranial neural crest cells during
  embryogenesis. Published prevalence estimates range from approximately 1 in
  50,000 to 1 in 80,000, and intellect is typically normal.
category: Mendelian
parents:
- Mandibulofacial dysostosis
disease_term:
  preferred_term: Treacher Collins syndrome
  term:
    id: MONDO:0002457
    label: Treacher-Collins syndrome
has_subtypes:
- name: TCS1
  display_name: Treacher Collins Syndrome 1 (TCOF1)
  description: >-
    The most common subtype, caused by heterozygous pathogenic variants in
    TCOF1 encoding Treacle, a nucleolar phosphoprotein required for ribosomal
    DNA transcription and ribosome biogenesis.
  subtype_term:
    preferred_term: Treacher Collins syndrome 1
    term:
      id: MONDO:0007944
      label: Treacher Collins syndrome 1
  evidence:
  - reference: PMID:34573374
    reference_title: 'Treacher Collins Syndrome: Genetics, Clinical Features and Management.'
    supports: SUPPORT
    evidence_source: OTHER
    snippet: TCS can be caused by pathogenic variants in the TCOF1, POLR1D, POLR1C and POLR1B genes. Genetically, the TCOF1 gene contains 27 exons which encodes the Treacle protein. In TCOF1, over 200 pathogenic variants have been identified
    explanation: Identifies TCOF1 as a causative gene for TCS with over 200 known pathogenic variants.
- name: TCS2
  display_name: Treacher Collins Syndrome 2 (POLR1D, AD or rare AR)
  description: >-
    Caused by heterozygous pathogenic variants in POLR1D or, rarely, by
    biallelic POLR1D variants. POLR1D encodes a subunit shared by RNA
    polymerases I and III.
  subtype_term:
    preferred_term: Treacher Collins syndrome 2
    term:
      id: MONDO:0013385
      label: Treacher Collins syndrome 2
  evidence:
  - reference: PMID:20301704
    reference_title: Treacher Collins Syndrome.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: heterozygous pathogenic variant in TCOF1, POLR1D, or POLR1B, biallelic pathogenic variants in POLR1C, or, rarely, biallelic pathogenic variants in POLR1D identified by molecular genetic testing.
    explanation: GeneReviews lists POLR1D heterozygous variants as a diagnostic criterion for TCS.
- name: TCS3
  display_name: Treacher Collins Syndrome 3 (POLR1C, AR)
  description: Caused by biallelic pathogenic variants in POLR1C, encoding a subunit shared by RNA polymerases I and III. Autosomal recessive inheritance.
  subtype_term:
    preferred_term: Treacher Collins syndrome 3
    term:
      id: MONDO:0009558
      label: Treacher Collins syndrome 3
  evidence:
  - reference: PMID:20301704
    reference_title: Treacher Collins Syndrome.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: Autosomal recessive inheritance (biallelic pathogenic variants in POLR1C or POLR1D) accounts for a minority of TCS.
    explanation: GeneReviews confirms biallelic POLR1C variants cause autosomal recessive TCS.
- name: TCS4
  display_name: Treacher Collins Syndrome 4 (POLR1B)
  description: Caused by heterozygous pathogenic variants in POLR1B, encoding the second largest subunit of RNA polymerase I.
  subtype_term:
    preferred_term: Treacher Collins syndrome 4
    term:
      id: MONDO:0030067
      label: Treacher Collins syndrome 4
  evidence:
  - reference: PMID:34573374
    reference_title: 'Treacher Collins Syndrome: Genetics, Clinical Features and Management.'
    supports: SUPPORT
    evidence_source: OTHER
    snippet: Four subtypes of Treacher Collins syndrome exist. TCS can be caused by pathogenic variants in the TCOF1, POLR1D, POLR1C and POLR1B genes.
    explanation: Identifies POLR1B as one of the four causative genes defining TCS subtypes.
inheritance:
- name: Autosomal dominant inheritance
  description: >-
    Most TCS follows autosomal dominant inheritance with marked variable
    expressivity. About 55%-61% of autosomal dominant cases are de novo, and
    each child of an affected individual has a 50% chance of inheriting the
    pathogenic variant.
  inheritance_term:
    preferred_term: Autosomal dominant inheritance
    term:
      id: HP:0000006
      label: Autosomal dominant inheritance
  evidence:
  - reference: PMID:20301704
    reference_title: Treacher Collins Syndrome.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: Autosomal dominant inheritance accounts for most of TCS, most commonly heterozygous pathogenic variants in TCOF1 and less commonly heterozygous pathogenic variants in POLR1B or POLR1D.
    explanation: GeneReviews confirms autosomal dominant inheritance as the predominant pattern for TCS.
  - reference: PMID:20301704
    reference_title: Treacher Collins Syndrome.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: About 55%-61% of individuals with autosomal dominant TCS have the disorder as the result of a de novo pathogenic variant.
    explanation: High de novo rate explains sporadic cases.
  - reference: PMID:20301704
    reference_title: Treacher Collins Syndrome.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: Each child of an individual with autosomal dominant TCS has a 50% chance of inheriting the pathogenic variant.
    explanation: GeneReviews provides the recurrence risk for offspring in autosomal dominant TCS.
- name: Autosomal recessive inheritance
  description: >-
    A minority of TCS is caused by biallelic pathogenic variants in POLR1C or
    POLR1D. When both parents are heterozygous, each pregnancy has a 25% chance
    of an affected child, a 50% chance of a carrier, and a 25% chance of a child
    who is unaffected and not a carrier.
  inheritance_term:
    preferred_term: Autosomal recessive inheritance
    term:
      id: HP:0000007
      label: Autosomal recessive inheritance
  evidence:
  - reference: PMID:20301704
    reference_title: Treacher Collins Syndrome.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: Autosomal recessive inheritance (biallelic pathogenic variants in POLR1C or POLR1D) accounts for a minority of TCS.
    explanation: GeneReviews documents the autosomal recessive minority of TCS.
  - reference: PMID:20301704
    reference_title: Treacher Collins Syndrome.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      each sib of an individual with autosomal recessive TCS has at conception
      a 25% chance of being affected, a 50% chance of being an asymptomatic
      carrier, and a 25% chance of being unaffected and not a carrier.
    explanation: GeneReviews provides the sibling recurrence risks for autosomal recessive TCS.
classifications:
  isds_skeletal_category:
  - classification_value: dysostoses_with_predominant_craniofacial_involvement
    notes: >-
      ISDS Nosology of Genetic Skeletal Disorders, 2023 revision (Unger et al.,
      PMID:36779427), group 35 "Craniofacial Dysostoses"; Treacher Collins is
      listed among the mandibulofacial dysostoses. This supersedes its placement
      in group 34 of the 2019 revision.
prevalence:
- population: Worldwide
  measure_type: BIRTH_PREVALENCE
  prevalence_class: BAND_1_9_PER_100000
  rate_per_100000: 2.0
  percentage: 0.002
  notes: >-
    Published estimates differ: the 2021 review cites approximately 1 in 50,000
    live births (2 per 100,000), while the 2024 GeneReviews update cites an
    estimated prevalence of 1 in 80,000. The structured value retains the
    directly stated birth-frequency estimate and should not be read as precise.
  evidence:
  - reference: PMID:34573374
    reference_title: 'Treacher Collins Syndrome: Genetics, Clinical Features and Management.'
    supports: SUPPORT
    evidence_source: OTHER
    snippet: TCS occurs in the general population at a frequency of 1 in 50,000 live births.
    explanation: Directly states the prevalence of TCS.
  - reference: url:https://www.ncbi.nlm.nih.gov/books/NBK1532/
    reference_title: Treacher Collins Syndrome - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    snippet: The prevalence of TCS is estimated at 1:80,000
    explanation: The current GeneReviews estimate documents uncertainty around the older 1:50,000 birth-frequency figure.
pathophysiology:
- name: Impaired Ribosome Biogenesis in Neural Crest Cells
  conforms_to: pharyngeal_arch_patterning_serial_homology#Cranial Neural Crest and Pharyngeal Arch Program Perturbation
  biological_scale: MOLECULAR
  description: >-
    Dominant TCOF1, POLR1B, or POLR1D loss of function and biallelic
    POLR1C/POLR1D loss of function collectively disrupt one or more RNA
    polymerase I-associated steps in rRNA transcription, rRNA processing, and
    production of mature ribosomes. Cranial neural crest and neuroepithelial
    cells are selectively vulnerable to this nucleolar stress during early
    craniofacial development.
  genes:
  - preferred_term: TCOF1
    term:
      id: hgnc:11654
      label: TCOF1
  - preferred_term: POLR1B
    term:
      id: hgnc:20454
      label: POLR1B
  - preferred_term: POLR1C
    term:
      id: hgnc:20194
      label: POLR1C
  - preferred_term: POLR1D
    term:
      id: hgnc:20422
      label: POLR1D
  cell_types:
  - preferred_term: Migratory neural crest cell
    term:
      id: CL:0000333
      label: migratory neural crest cell
  biological_processes:
  - preferred_term: Ribosome biogenesis
    term:
      id: GO:0042254
      label: ribosome biogenesis
    modifier: DECREASED
  locations:
  - preferred_term: Pharyngeal arch
    term:
      id: UBERON:0002539
      label: pharyngeal arch
  evidence:
  - reference: PMID:16938878
    reference_title: Tcof1/Treacle is required for neural crest cell formation and proliferation deficiencies that cause craniofacial abnormalities.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: Tcof1/Treacle regulates proliferation by controlling the production of mature ribosomes.
    explanation: The Tcof1 mouse model directly links Treacle dosage to mature-ribosome production.
  - reference: PMID:29364875
    reference_title: Tissue-selective effects of nucleolar stress and rDNA damage in developmental disorders.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      genetic perturbations associated with Treacher Collins syndrome, a
      craniofacial disorder caused by heterozygous mutations in components of
      the Pol I transcriptional machinery or its cofactor TCOF1 (ref. 1), lead
      to relocalization of DDX21 from the nucleolus to the nucleoplasm, its loss
      from the chromatin targets, as well as inhibition of rRNA processing and
      downregulation of ribosomal protein gene transcription.
    explanation: Human-cell perturbations show the shared nucleolar and rRNA-processing defect.
  - reference: PMID:24690222
    reference_title: "Treacher Collins Syndrome: the genetics of a craniofacial disease."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      The association of the TCOF1 gene product, Treacle, and gene products of
      POLR1C and POLR1D with ribosome biosynthesis suggests that a loss of
      function mutation in these genes disrupts ribosome biosynthesis in
      constituent neural crest cells and neuroepithelium leading to apoptosis.
    explanation: This review supplies cross-gene context; the primary-model evidence above supports the mechanistic nodes.
  - reference: PMID:31649276
    reference_title: POLR1B and neural crest cell anomalies in Treacher Collins syndrome type 4.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Knockdown of polr1b in zebrafish induced an abnormal craniofacial
      phenotype mimicking TCS that was associated with altered ribosomal gene
      expression, massive p53-associated cellular apoptosis in the
      neuroepithelium, and reduced number of NCC derivatives.
    explanation: The primary TCS4 study supplies gene-local support that POLR1B perturbation disrupts ribosomal expression and the shared neural-crest mechanism.
  - reference: PMID:27448281
    reference_title: The Roles of RNA Polymerase I and III Subunits Polr1c and Polr1d in Craniofacial Development and in Zebrafish Models of Treacher Collins Syndrome.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Mechanistically, we discovered that polr1c and polr1d loss-of-function
      results in deficient ribosome biogenesis, Tp53-dependent neuroepithelial
      cell death and a deficiency of migrating neural crest cells, which are
      the primary progenitors of the craniofacial skeleton.
    explanation: Stable polr1c and polr1d mutant zebrafish provide gene-local primary evidence for the shared ribosome-biogenesis defect.
  downstream:
  - target: p53-Dependent Neuroepithelial Apoptosis
    causal_link_type: DIRECT
    description: Nucleolar stress stabilizes p53 and activates apoptosis in neuroepithelial and neural crest progenitor cells.
    evidence:
    - reference: PMID:18246078
      reference_title: Prevention of the neurocristopathy Treacher Collins syndrome through inhibition of p53 function.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        Haploinsufficiency of Tcof1 perturbs mature ribosome biogenesis,
        resulting in stabilization of p53 and the cyclin G1-mediated cell-cycle
        arrest that underpins the specificity of neuroepithelial apoptosis and
        neural crest cell hypoplasia characteristic of TCS.
      explanation: The mouse model directly connects impaired ribosome biogenesis to p53 stabilization and apoptosis.
- name: TCOF1-Associated Oxidative DNA Damage
  biological_scale: CELLULAR
  description: >-
    In TCOF1-associated TCS, reduced Treacle-dependent DNA-damage response and
    repair increase oxidative DNA damage in the embryonic neuroepithelium. This
    is a TCOF1-specific parallel input to cell death and should not be assumed
    for every POLR1B/POLR1C/POLR1D genotype.
  genes:
  - preferred_term: TCOF1
    term:
      id: hgnc:11654
      label: TCOF1
  cell_types:
  - preferred_term: Neuroepithelial cell
    term:
      id: CL:0000710
      label: neurecto-epithelial cell
  biological_processes:
  - preferred_term: Cellular response to oxidative stress
    term:
      id: GO:0034599
      label: cellular response to oxidative stress
    modifier: ABNORMAL
  locations:
  - preferred_term: Neural tube
    term:
      id: UBERON:0001049
      label: neural tube
  evidence:
  - reference: PMID:26792133
    reference_title: Prevention of Treacher Collins syndrome craniofacial anomalies in mouse models via maternal antioxidant supplementation.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: Tcof1 haploinsufficiency results in oxidative stress-induced DNA damage and neuroepithelial cell death.
    explanation: The Tcof1 mouse model identifies oxidative DNA damage as a parallel Treacle-dependent mechanism.
  downstream:
  - target: p53-Dependent Neuroepithelial Apoptosis
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: Oxidative DNA damage activates checkpoint signaling that converges on apoptotic neuroepithelial cell loss.
    intermediate_mechanisms:
    - Chk2 checkpoint activation
    - p53 stabilization
    evidence:
    - reference: PMID:26792133
      reference_title: Prevention of Treacher Collins syndrome craniofacial anomalies in mouse models via maternal antioxidant supplementation.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: Tcof1 haploinsufficiency results in oxidative stress-induced DNA damage and neuroepithelial cell death.
      explanation: Oxidative DNA damage and neuroepithelial cell death co-occur in the rescue model; the intervening checkpoint-to-p53 steps are not isolated by this excerpt.
- name: p53-Dependent Neuroepithelial Apoptosis
  biological_scale: CELLULAR
  description: >-
    Ribosomal/nucleolar stress, and in TCOF1 deficiency oxidative DNA damage,
    stabilize p53 and drive excessive apoptosis during the developmental window
    that generates cranial neural crest cells. Genetic or pharmacologic p53
    inhibition rescues craniofacial development in animal models without
    restoring ribosome biogenesis, supporting apoptosis as a downstream
    effector rather than p53 inhibition as an established human treatment.
  cell_types:
  - preferred_term: Neuroepithelial cell
    term:
      id: CL:0000710
      label: neurecto-epithelial cell
  biological_processes:
  - preferred_term: Apoptotic process
    term:
      id: GO:0006915
      label: apoptotic process
    modifier: INCREASED
  locations:
  - preferred_term: Neural tube
    term:
      id: UBERON:0001049
      label: neural tube
  evidence:
  - reference: PMID:18246078
    reference_title: Prevention of the neurocristopathy Treacher Collins syndrome through inhibition of p53 function.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      inhibition of p53 prevents cyclin G1-driven apoptotic elimination of
      neural crest cells while rescuing the craniofacial abnormalities associated
      with mutations in Tcof1 and extending life span.
    explanation: Rescue by p53 inhibition establishes the p53-apoptosis effector in Tcof1-deficient embryos.
  - reference: PMID:38556235
    reference_title: p53 inhibitor or antioxidants reduce the severity of ethmoid plate deformities in zebrafish Type 3 Treacher Collins syndrome model.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      The pathogenesis of TCS-3 linked to polr1c involves the activation of
      apoptosis-dependent p53 pathways within neural crest cells (NCCs).
    explanation: A POLR1C-deficient zebrafish model extends the p53-apoptosis mechanism beyond TCOF1.
  downstream:
  - target: Cranial Neural Crest Cell Deficiency
    causal_link_type: DIRECT
    description: Excess apoptosis reduces the generation and survival of migrating cranial neural crest cells.
    evidence:
    - reference: PMID:18246078
      reference_title: Prevention of the neurocristopathy Treacher Collins syndrome through inhibition of p53 function.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        inhibition of p53 prevents cyclin G1-driven apoptotic elimination of
        neural crest cells while rescuing the craniofacial abnormalities associated
        with mutations in Tcof1 and extending life span.
      explanation: Prevention of apoptotic neural crest elimination rescues the modeled phenotype.
- name: Cranial Neural Crest Cell Deficiency
  conforms_to: pharyngeal_arch_patterning_serial_homology#Disrupted Pharyngeal-Arch Patterning and Neural-Crest Skeletogenesis
  biological_scale: CELLULAR
  description: >-
    Reduced formation, proliferation, survival, and migration leave too few
    cranial neural crest cells to populate the first and second pharyngeal
    arches. Human TCOF1-haploinsufficient neural crest cells independently show
    a migration defect, so this node is a population-level developmental state
    rather than apoptosis itself.
  cell_types:
  - preferred_term: Migratory neural crest cell
    term:
      id: CL:0000333
      label: migratory neural crest cell
  biological_processes:
  - preferred_term: Neural crest cell development
    term:
      id: GO:0014032
      label: neural crest cell development
    modifier: ABNORMAL
  - preferred_term: Neural crest cell migration
    term:
      id: GO:0001755
      label: neural crest cell migration
    modifier: DECREASED
  locations:
  - preferred_term: Pharyngeal arch
    term:
      id: UBERON:0002539
      label: pharyngeal arch
  evidence:
  - reference: PMID:16938878
    reference_title: Tcof1/Treacle is required for neural crest cell formation and proliferation deficiencies that cause craniofacial abnormalities.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: Haploinsufficiency of Tcof1 leads to a deficiency in migrating neural crest cells, which results in severe craniofacial malformations.
    explanation: The Tcof1 mouse model directly demonstrates the neural crest population deficit.
  - reference: PMID:30375284
    reference_title: A Novel Human Pluripotent Stem Cell-Derived Neural Crest Model of Treacher Collins Syndrome Shows Defects in Cell Death and Migration.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: We also report for the first time an impairment of migration in TCOF1+/- NC and mesenchymal stem cells.
    explanation: Human TCOF1-haploinsufficient neural crest cells show impaired migration in vitro.
  downstream:
  - target: Serial Craniofacial Arch-Derivative Maldevelopment
    causal_link_type: DIRECT
    description: Too few competent cranial neural crest cells populate and form the skeletal and connective-tissue derivatives of the first and second arches.
    evidence:
    - reference: PMID:16938878
      reference_title: Tcof1/Treacle is required for neural crest cell formation and proliferation deficiencies that cause craniofacial abnormalities.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: Haploinsufficiency of Tcof1 leads to a deficiency in migrating neural crest cells, which results in severe craniofacial malformations.
      explanation: The model directly connects neural crest deficiency to craniofacial malformation.
- name: Serial Craniofacial Arch-Derivative Maldevelopment
  conforms_to: pharyngeal_arch_patterning_serial_homology#Serially Homologous Craniofacial Malformation Across Arch Derivatives
  biological_scale: TISSUE
  description: >-
    Deficient cranial neural crest contribution produces a coordinated,
    typically bilateral malformation bundle across serial first- and
    second-pharyngeal-arch derivatives: zygoma, maxilla, mandible, external and
    middle ear, palate, and periocular soft tissues.
  locations:
  - preferred_term: mandible
    term:
      id: UBERON:0001684
      label: mandible
  - preferred_term: zygomatic bone
    term:
      id: UBERON:0001683
      label: jugal bone
  biological_processes:
  - preferred_term: Embryonic cranial skeleton morphogenesis
    term:
      id: GO:0048701
      label: embryonic cranial skeleton morphogenesis
    modifier: ABNORMAL
  evidence:
  - reference: PMID:20301704
    reference_title: Treacher Collins Syndrome.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: Treacher Collins syndrome (TCS) is characterized by lower eyelid abnormalities, malar hypoplasia, downslanted palpebral fissures, and micro- or retrognathia due to symmetric hypoplasia of the zygomatic bones, maxilla, and mandible.
    explanation: GeneReviews describes the characteristic bilateral symmetric craniofacial skeletal hypoplasia.
  downstream:
  - target: Malar Flattening
    description: Zygomatic and midface hypoplasia produces malar flattening.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:20301704
      reference_title: Treacher Collins Syndrome.
      supports: SUPPORT
      evidence_source: OTHER
      snippet: Treacher Collins syndrome (TCS) is characterized by lower eyelid abnormalities, malar hypoplasia, downslanted palpebral fissures, and micro- or retrognathia due to symmetric hypoplasia of the zygomatic bones, maxilla, and mandible.
      explanation: GeneReviews explicitly connects malar hypoplasia with the underlying symmetric skeletal hypoplasia.
  - target: Micrognathia
    description: Mandibular hypoplasia produces micrognathia.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:20301704
      reference_title: Treacher Collins Syndrome.
      supports: SUPPORT
      evidence_source: OTHER
      snippet: Treacher Collins syndrome (TCS) is characterized by lower eyelid abnormalities, malar hypoplasia, downslanted palpebral fissures, and micro- or retrognathia due to symmetric hypoplasia of the zygomatic bones, maxilla, and mandible.
      explanation: GeneReviews explicitly attributes micro-/retrognathia to symmetric mandibular hypoplasia.
  - target: Downslanted Palpebral Fissures
    description: Orbital and periocular craniofacial maldevelopment produces downslanted palpebral fissures.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:20301704
      reference_title: Treacher Collins Syndrome.
      supports: SUPPORT
      evidence_source: OTHER
      snippet: Treacher Collins syndrome (TCS) is characterized by lower eyelid abnormalities, malar hypoplasia, downslanted palpebral fissures, and micro- or retrognathia due to symmetric hypoplasia of the zygomatic bones, maxilla, and mandible.
      explanation: The defining arch-derivative phenotype includes the periocular fissure abnormality.
  - target: Lower Eyelid Coloboma
    description: Periocular craniofacial maldevelopment produces lower eyelid coloboma.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:34573374
      reference_title: "Treacher Collins Syndrome: Genetics, Clinical Features and Management."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: Features of TCS include microtia with conductive hearing loss, slanting palpebral fissures with possibly coloboma of the lateral part of lower eyelids, midface hypoplasia, micrognathia as well as sporadically cleft palate and choanal atresia or stenosis.
      explanation: The review places lower-eyelid coloboma in the same craniofacial malformation bundle.
  - target: Microtia
    description: First and second pharyngeal arch maldevelopment produces external ear malformations including microtia.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:20301704
      reference_title: Treacher Collins Syndrome.
      supports: SUPPORT
      evidence_source: OTHER
      snippet: External ear anomalies include absent, small, malformed, and/or posteriorly rotated ears and atresia or stenosis of the external auditory canals.
      explanation: GeneReviews documents the external-ear derivative abnormalities represented by microtia.
  - target: Atresia of External Auditory Canal
    description: Ear canal maldevelopment produces atresia or stenosis of the external auditory canal.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:20301704
      reference_title: Treacher Collins Syndrome.
      supports: SUPPORT
      evidence_source: OTHER
      snippet: External ear anomalies include absent, small, malformed, and/or posteriorly rotated ears and atresia or stenosis of the external auditory canals.
      explanation: GeneReviews directly documents atresia/stenosis as part of the external-ear developmental phenotype.
  - target: Conductive Hearing Loss
    description: External and middle ear malformations impair sound conduction.
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - ossicle malformation
    - middle ear cavity hypoplasia
    evidence:
    - reference: PMID:20301704
      reference_title: Treacher Collins Syndrome.
      supports: SUPPORT
      evidence_source: OTHER
      snippet: About 40%-50% of individuals have conductive hearing loss attributed most commonly to malformation of the ossicles and hypoplasia of the middle ear cavities.
      explanation: GeneReviews directly specifies both known intermediates and their conductive-hearing consequence.
  - target: Cleft Palate
    description: Abnormal pharyngeal arch and palatal development can produce cleft palate.
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - palatal maldevelopment
    evidence:
    - reference: PMID:34573374
      reference_title: "Treacher Collins Syndrome: Genetics, Clinical Features and Management."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: Features of TCS include microtia with conductive hearing loss, slanting palpebral fissures with possibly coloboma of the lateral part of lower eyelids, midface hypoplasia, micrognathia as well as sporadically cleft palate and choanal atresia or stenosis.
      explanation: The review supports cleft palate within the arch-malformation bundle but does not resolve its intermediate steps.
  - target: Choanal Atresia
    description: Craniofacial maldevelopment can include choanal stenosis or atresia.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:20301704
      reference_title: Treacher Collins Syndrome.
      supports: SUPPORT
      evidence_source: OTHER
      snippet: Other, less common abnormalities include cleft palate and unilateral or bilateral choanal stenosis or atresia.
      explanation: GeneReviews supports inclusion in the craniofacial phenotype while the specific developmental bridge remains unknown.
  - target: Upper Airway Obstruction
    description: Mandibular hypoplasia and glossoptosis narrow the upper airway.
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - micrognathia
    - glossoptosis
    evidence:
    - reference: url:https://www.ncbi.nlm.nih.gov/books/NBK1532/
      reference_title: Treacher Collins Syndrome - GeneReviews® - NCBI Bookshelf
      supports: SUPPORT
      evidence_source: OTHER
      snippet: Choanal atresia/stenosis or severe micrognathia with glossoptosis can obstruct the airway in an infant from the time of delivery
      explanation: The current GeneReviews text directly states the structural routes to airway obstruction.
  - target: Feeding Difficulties
    description: Mandibular hypoplasia and cleft palate can impair infant feeding.
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - micrognathia
    - cleft palate
    evidence:
    - reference: PMID:20301704
      reference_title: Treacher Collins Syndrome.
      supports: SUPPORT
      evidence_source: OTHER
      snippet: Significant respiratory and feeding difficulties can be present in infancy.
      explanation: GeneReviews supports infant feeding difficulty; the listed anatomical intermediates are clinically plausible but not isolated experimentally.
  - target: Obstructive Sleep Apnea
    description: Mandibular hypoplasia and upper airway narrowing predispose to obstructive sleep apnea.
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - upper airway obstruction
    evidence:
    - reference: PMID:20301704
      reference_title: Treacher Collins Syndrome.
      supports: SUPPORT
      evidence_source: OTHER
      snippet: assess for manifestations of obstructive sleep apnea, growth, and caloric intake at each visit
      explanation: Surveillance guidance establishes OSA as an airway-associated TCS manifestation; the causal chain is not quantified.
  - target: Sparse Lower Eyelid Eyelashes
    description: Lower-eyelid developmental abnormalities can include partial absence of eyelashes.
    causal_link_type: DIRECT
    evidence:
    - reference: url:https://www.ncbi.nlm.nih.gov/books/NBK1532/
      reference_title: Treacher Collins Syndrome - GeneReviews® - NCBI Bookshelf
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        Primary ocular anomalies were described in almost all individuals, mostly
        consisting of downslanted palpebral fissures (93.8%), colobomata of the
        lower eyelids (69.6%), and (partial) absence of lower lid eyelashes
        (42.8%).
      explanation: The ocular cohort summarized in GeneReviews groups absent lashes with primary lower-eyelid maldevelopment.
  - target: Strabismus
    description: Orbital and periocular maldevelopment can disturb ocular alignment.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:35032653
      reference_title: "Ocular and adnexal anomalies in Treacher Collins syndrome: a retrospective multicenter study."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Primary ocular anomalies were reported in 98.5% of cases, secondary
        anomalies in 34.5%, strabismus in 27.3%, refractive errors in 49.5%, and
        visual impairment in 4.6%.
      explanation: The cohort supports the association but not a resolved anatomical intermediate.
  - target: Abnormality of Refraction
    description: Ocular involvement frequently includes a refractive abnormality.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:35032653
      reference_title: "Ocular and adnexal anomalies in Treacher Collins syndrome: a retrospective multicenter study."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Primary ocular anomalies were reported in 98.5% of cases, secondary
        anomalies in 34.5%, strabismus in 27.3%, refractive errors in 49.5%, and
        visual impairment in 4.6%.
      explanation: The cohort supports the association but does not establish the developmental route to refractive error.
  - target: Delayed Speech and Language Development
    description: Conductive hearing impairment can delay speech and language development.
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - conductive hearing impairment
    evidence:
    - reference: PMID:38248782
      reference_title: "Systematic Review of Current Audiological Treatment Options for Patients with Treacher Collins Syndrome (TCS) and Surgical and Audiological Experiences of an Otorhinolaryngologist with TCS."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        speech comprehension improved after the use of bone conduction devices
        in Treacher Collins patients
      explanation: Improvement with hearing rehabilitation supports a hearing-mediated speech pathway, while developmental delay itself is not experimentally assigned.
  - target: Dental Anomalies
    description: Craniofacial and dentition development can produce dental anomalies requiring longitudinal dental and orthodontic care.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:38801252
      reference_title: "Optimal Diagnostic and Treatment Practices for Facial Dysostosis Syndromes: A Clinical Consensus Statement Among European Experts."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        Given the greater prevalence of dental anomalies,71 the experts also
        agreed on the benefit of at least one clinical and/or radiologic dental
        screening (168)
      explanation: The European consensus establishes the frequent dental association and screening need, while the developmental intermediates remain unspecified.
phenotypes:
- category: Clinical
  name: Malar Flattening
  description: Bilateral symmetric hypoplasia of the zygomatic bones causing characteristic flat midface appearance.
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Malar flattening
    term:
      id: HP:0000272
      label: Malar flattening
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/books/NBK1532/pdf/Bookshelf_NBK1532.pdf
    reference_title: https://www.ncbi.nlm.nih.gov/books/NBK1532/pdf/Bookshelf_NBK1532.pdf
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Table 2. Treacher Collins Syndrome: Frequency of Select Features Feature
      Frequency Downslanted palpebral fissures Very frequent (>75%) Malar
      hypoplasia / hypoplasia of zygomatic bones Conductive hearing loss
      Mandibular hypoplasia w/micro- or retrognathia
    explanation: GeneReviews Table 2 places malar hypoplasia in its very-frequent (>75%) feature group, supporting the structured qualitative band.
- category: Clinical
  name: Micrognathia
  description: Underdevelopment of the mandible, contributing to airway and feeding difficulties.
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Micrognathia
    term:
      id: HP:0000347
      label: Micrognathia
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/books/NBK1532/pdf/Bookshelf_NBK1532.pdf
    reference_title: https://www.ncbi.nlm.nih.gov/books/NBK1532/pdf/Bookshelf_NBK1532.pdf
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Table 2. Treacher Collins Syndrome: Frequency of Select Features Feature
      Frequency Downslanted palpebral fissures Very frequent (>75%) Malar
      hypoplasia / hypoplasia of zygomatic bones Conductive hearing loss
      Mandibular hypoplasia w/micro- or retrognathia
    explanation: GeneReviews Table 2 places mandibular hypoplasia with micro- or retrognathia in its very-frequent (>75%) feature group.
- category: Clinical
  name: Downslanted Palpebral Fissures
  description: Characteristic downward slanting of the palpebral fissures.
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Downslanted palpebral fissures
    term:
      id: HP:0000494
      label: Downslanted palpebral fissures
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/books/NBK1532/
    reference_title: Treacher Collins Syndrome - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Primary ocular anomalies were described in almost all individuals, mostly
      consisting of downslanted palpebral fissures (93.8%), colobomata of the
      lower eyelids (69.6%), and (partial) absence of lower lid eyelashes
      (42.8%).
    explanation: The updated GeneReviews chapter reports downslanted palpebral fissures in 93.8%, within the VERY_FREQUENT band.
- category: Clinical
  name: Conductive Hearing Loss
  description: Conductive hearing loss affecting approximately 40-50% of individuals, due to malformation of the ossicles and hypoplasia of the middle ear cavities.
  phenotype_term:
    preferred_term: Conductive hearing impairment
    term:
      id: HP:0000405
      label: Conductive hearing impairment
  evidence:
  - reference: PMID:20301704
    reference_title: Treacher Collins Syndrome.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: About 40%-50% of individuals have conductive hearing loss attributed most commonly to malformation of the ossicles and hypoplasia of the middle ear cavities.
    explanation: GeneReviews specifies the frequency and mechanism of conductive hearing loss in TCS.
  frequency: FREQUENT
- category: Clinical
  name: Microtia
  description: Absent, small, malformed, or posteriorly rotated ears.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Microtia
    term:
      id: HP:0008551
      label: Microtia
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/books/NBK1532/pdf/Bookshelf_NBK1532.pdf
    reference_title: https://www.ncbi.nlm.nih.gov/books/NBK1532/pdf/Bookshelf_NBK1532.pdf
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Table 2. continued from previous page. Feature Frequency Atresia of
      external ear canal Frequent (30%-75%) Microtia
    explanation: GeneReviews Table 2 places microtia in its frequent (30%-75%) feature group.
- category: Clinical
  name: Atresia of External Auditory Canal
  description: Atresia or stenosis of the external auditory canals.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Atresia of the external auditory canal
    term:
      id: HP:0000413
      label: Atresia of the external auditory canal
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/books/NBK1532/pdf/Bookshelf_NBK1532.pdf
    reference_title: https://www.ncbi.nlm.nih.gov/books/NBK1532/pdf/Bookshelf_NBK1532.pdf
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Table 2. continued from previous page. Feature Frequency Atresia of
      external ear canal Frequent (30%-75%)
    explanation: GeneReviews Table 2 places external-auditory-canal atresia in its frequent (30%-75%) feature group.
- category: Clinical
  name: Lower Eyelid Coloboma
  description: Coloboma of the lateral part of the lower eyelids, a distinctive feature.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Lower eyelid coloboma
    term:
      id: HP:0000652
      label: Lower eyelid coloboma
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/books/NBK1532/
    reference_title: Treacher Collins Syndrome - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Primary ocular anomalies were described in almost all individuals, mostly
      consisting of downslanted palpebral fissures (93.8%), colobomata of the
      lower eyelids (69.6%), and (partial) absence of lower lid eyelashes
      (42.8%).
    explanation: The updated GeneReviews chapter reports lower-eyelid colobomata in 69.6%, within the FREQUENT band.
- category: Clinical
  name: Cleft Palate
  description: Cleft palate occurs in a subset of TCS patients.
  frequency: OCCASIONAL
  phenotype_term:
    preferred_term: Cleft palate
    term:
      id: HP:0000175
      label: Cleft palate
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/books/NBK1532/pdf/Bookshelf_NBK1532.pdf
    reference_title: https://www.ncbi.nlm.nih.gov/books/NBK1532/pdf/Bookshelf_NBK1532.pdf
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Delayed speech development Dental anomalies Preauricular hair
      displacement Cleft palate Less common (10%-30%)
    explanation: GeneReviews Table 2 places cleft palate in its less-common (10%-30%) feature group, matching the OCCASIONAL structured band.
- category: Clinical
  name: Choanal Atresia
  description: Unilateral or bilateral choanal stenosis or atresia occurs in some patients with TCS.
  frequency: OCCASIONAL
  phenotype_term:
    preferred_term: Choanal atresia
    term:
      id: HP:0000453
      label: Choanal atresia
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/books/NBK1532/pdf/Bookshelf_NBK1532.pdf
    reference_title: https://www.ncbi.nlm.nih.gov/books/NBK1532/pdf/Bookshelf_NBK1532.pdf
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Cleft palate Less common (10%-30%)Choanal stenosis/atresia Cardiac
      malformation Rachis malformation
    explanation: GeneReviews Table 2 places choanal stenosis/atresia in its less-common (10%-30%) feature group, matching the OCCASIONAL structured band.
- category: Clinical
  name: Upper Airway Obstruction
  description: Respiratory difficulties from mandibular hypoplasia and glossoptosis, which may require airway management at birth.
  phenotype_term:
    preferred_term: Upper airway obstruction
    term:
      id: HP:0002781
      label: Upper airway obstruction
  evidence:
  - reference: PMID:20301704
    reference_title: Treacher Collins Syndrome.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: Neonates with airway issues may require airway management at delivery, special positioning, or tracheostomy to facilitate ventilation.
    explanation: GeneReviews describes significant airway obstruction requiring intervention in some neonates.
- category: Clinical
  name: Feeding Difficulties
  description: Feeding difficulties in infancy due to mandibular hypoplasia and possible cleft palate.
  phenotype_term:
    preferred_term: Feeding difficulties
    term:
      id: HP:0011968
      label: Feeding difficulties
  evidence:
  - reference: PMID:20301704
    reference_title: Treacher Collins Syndrome.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: Significant respiratory and feeding difficulties can be present in infancy.
    explanation: GeneReviews identifies feeding difficulties as a significant neonatal concern.
- category: Clinical
  name: Obstructive Sleep Apnea
  description: Obstructive sleep apnea due to mandibular hypoplasia and upper airway narrowing; annual surveillance recommended.
  phenotype_term:
    preferred_term: Obstructive sleep apnea
    term:
      id: HP:0002870
      label: Obstructive sleep apnea
  evidence:
  - reference: PMID:20301704
    reference_title: Treacher Collins Syndrome.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: assess for manifestations of obstructive sleep apnea, growth, and caloric intake at each visit
    explanation: GeneReviews surveillance recommendations include assessment for OSA at each visit.
- category: Ophthalmologic
  name: Sparse Lower Eyelid Eyelashes
  description: Partial or complete absence of lower-lid eyelashes is part of the characteristic lower-eyelid phenotype.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Sparse lower eyelashes
    term:
      id: HP:0007776
      label: Sparse lower eyelashes
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/books/NBK1532/
    reference_title: Treacher Collins Syndrome - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Primary ocular anomalies were described in almost all individuals, mostly
      consisting of downslanted palpebral fissures (93.8%), colobomata of the
      lower eyelids (69.6%), and (partial) absence of lower lid eyelashes
      (42.8%).
    explanation: The updated GeneReviews chapter reports absent lower-lid eyelashes in 42.8%, within the FREQUENT band.
- category: Ophthalmologic
  name: Strabismus
  description: Ocular misalignment is a secondary ophthalmologic manifestation.
  frequency: OCCASIONAL
  phenotype_term:
    preferred_term: Strabismus
    term:
      id: HP:0000486
      label: Strabismus
  evidence:
  - reference: PMID:35032653
    reference_title: "Ocular and adnexal anomalies in Treacher Collins syndrome: a retrospective multicenter study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Primary ocular anomalies were reported in 98.5% of cases, secondary
      anomalies in 34.5%, strabismus in 27.3%, refractive errors in 49.5%, and
      visual impairment in 4.6%.
    explanation: Strabismus in 27.3% of the 194-person cohort falls in the OCCASIONAL band.
- category: Ophthalmologic
  name: Abnormality of Refraction
  description: Refractive errors are common and require formal ophthalmologic assessment.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Abnormality of refraction
    term:
      id: HP:0000539
      label: Abnormality of refraction
  evidence:
  - reference: PMID:35032653
    reference_title: "Ocular and adnexal anomalies in Treacher Collins syndrome: a retrospective multicenter study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Primary ocular anomalies were reported in 98.5% of cases, secondary
      anomalies in 34.5%, strabismus in 27.3%, refractive errors in 49.5%, and
      visual impairment in 4.6%.
    explanation: Refractive errors in 49.5% of the cohort fall in the FREQUENT band.
- category: Developmental
  name: Delayed Speech and Language Development
  description: Speech development can be delayed, particularly when conductive hearing loss is not corrected early.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Delayed speech and language development
    term:
      id: HP:0000750
      label: Delayed speech and language development
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/books/NBK1532/pdf/Bookshelf_NBK1532.pdf
    reference_title: https://www.ncbi.nlm.nih.gov/books/NBK1532/pdf/Bookshelf_NBK1532.pdf
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Atresia of external ear canal Frequent (30%-75%) Microtia Coloboma
      (notching) of lower lid Delayed speech development
    explanation: GeneReviews Table 2 places delayed speech development in its frequent (30%-75%) feature group.
- category: Dental
  name: Dental Anomalies
  description: Dental anomalies and malocclusion require clinical or radiologic dental assessment and longitudinal multidisciplinary care.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Dental anomalies
    term:
      id: HP:0000164
      label: Abnormality of the dentition
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/books/NBK1532/pdf/Bookshelf_NBK1532.pdf
    reference_title: https://www.ncbi.nlm.nih.gov/books/NBK1532/pdf/Bookshelf_NBK1532.pdf
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Atresia of external ear canal Frequent (30%-75%) Microtia Coloboma
      (notching) of lower lid Delayed speech development Dental anomalies
    explanation: GeneReviews Table 2 places dental anomalies in its frequent (30%-75%) feature group.
genetic:
- name: TCOF1
  relationship_type: CAUSATIVE
  presence: Present
  subtype: TCS1
  gene_term:
    preferred_term: TCOF1
    term:
      id: hgnc:11654
      label: TCOF1
  inheritance:
  - name: Autosomal dominant
    inheritance_term:
      preferred_term: Autosomal dominant inheritance
      term:
        id: HP:0000006
        label: Autosomal dominant inheritance
    evidence:
    - reference: PMID:20301704
      reference_title: Treacher Collins Syndrome.
      supports: SUPPORT
      evidence_source: OTHER
      snippet: Autosomal dominant inheritance accounts for most of TCS, most commonly heterozygous pathogenic variants in TCOF1
      explanation: Confirms AD inheritance for TCOF1.
  notes: >-
    Encodes Treacle, a nucleolar phosphoprotein. More than 200 pathogenic
    variants have been reported, with truncating variants prominent. TCOF1 is
    the major TCS gene, but a fixed >90% attribution is not used here because
    ascertainment and panel composition differ across cohorts.
  evidence:
  - reference: PMID:34573374
    reference_title: 'Treacher Collins Syndrome: Genetics, Clinical Features and Management.'
    supports: SUPPORT
    evidence_source: OTHER
    snippet: the TCOF1 gene contains 27 exons which encodes the Treacle protein. In TCOF1, over 200 pathogenic variants have been identified, of which most are deletions leading to a frame-shift, that result in the formation of a termination codon.
    explanation: Details the molecular genetics of TCOF1 mutations in TCS.
  - reference: PMID:33804586
    reference_title: 'The Role of TCOF1 Gene in Health and Disease: Beyond Treacher Collins Syndrome.'
    supports: SUPPORT
    evidence_source: OTHER
    snippet: One of the crucial proteins involved in most of the key nucleolar functions is treacle phosphoprotein encoded by the TCOF1 gene.
    explanation: Identifies Treacle as a key nucleolar protein central to ribosome biogenesis.
  - reference: PMID:39920764
    reference_title: "Deciphering TCOF1 mutations in Chinese Treacher Collins syndrome patients: insights into pathogenesis and transcriptional disruption."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We identified 11 mutations predominantly localized to the central repeat
      domain (CRD) and the C-terminal domain (CTD, including the nuclear
      localization sequence) of TCOF1.
    explanation: A 2025 Chinese cohort expands the observed TCOF1 variant spectrum without supplying a universal gene-attribution percentage.
  - reference: PMID:39920764
    reference_title: "Deciphering TCOF1 mutations in Chinese Treacher Collins syndrome patients: insights into pathogenesis and transcriptional disruption."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Immunoprecipitation assays revealed that this pathogenic mutation
      attenuates the interaction between TCOF1 and transcription-related
      proteins, such as Pol II. Furthermore, cellular luciferase assays
      demonstrated that the mutation compromises the nuclear localization
      capability of TCOF1.
    explanation: Variant-expression assays support disrupted protein interactions and localization for the tested frameshift allele.
- name: POLR1D
  relationship_type: CAUSATIVE
  presence: Present
  subtype: TCS2
  gene_term:
    preferred_term: POLR1D
    term:
      id: hgnc:20422
      label: POLR1D
  inheritance:
  - name: Autosomal dominant
    inheritance_term:
      preferred_term: Autosomal dominant inheritance
      term:
        id: HP:0000006
        label: Autosomal dominant inheritance
    evidence:
    - reference: PMID:20301704
      reference_title: Treacher Collins Syndrome.
      supports: SUPPORT
      evidence_source: OTHER
      snippet: less commonly heterozygous pathogenic variants in POLR1B or POLR1D
      explanation: Confirms AD inheritance for POLR1D heterozygous variants.
  - name: Autosomal recessive
    inheritance_term:
      preferred_term: Autosomal recessive inheritance
      term:
        id: HP:0000007
        label: Autosomal recessive inheritance
    evidence:
    - reference: PMID:20301704
      reference_title: Treacher Collins Syndrome.
      supports: SUPPORT
      evidence_source: OTHER
      snippet: Autosomal recessive inheritance (biallelic pathogenic variants in POLR1C or POLR1D) accounts for a minority of TCS.
      explanation: GeneReviews confirms biallelic POLR1D variants cause AR TCS.
  notes: Encodes a subunit shared by RNA polymerases I and III. Both heterozygous (AD) and biallelic (AR) pathogenic variants can cause TCS.
  evidence:
  - reference: PMID:34573374
    reference_title: 'Treacher Collins Syndrome: Genetics, Clinical Features and Management.'
    supports: SUPPORT
    evidence_source: OTHER
    snippet: TCS can be caused by pathogenic variants in the TCOF1, POLR1D, POLR1C and POLR1B genes.
    explanation: Lists POLR1D as a causative gene for TCS.
- name: POLR1C
  relationship_type: CAUSATIVE
  presence: Present
  subtype: TCS3
  gene_term:
    preferred_term: POLR1C
    term:
      id: hgnc:20194
      label: POLR1C
  inheritance:
  - name: Autosomal recessive
    inheritance_term:
      preferred_term: Autosomal recessive inheritance
      term:
        id: HP:0000007
        label: Autosomal recessive inheritance
    evidence:
    - reference: PMID:20301704
      reference_title: Treacher Collins Syndrome.
      supports: SUPPORT
      evidence_source: OTHER
      snippet: Autosomal recessive inheritance (biallelic pathogenic variants in POLR1C or POLR1D) accounts for a minority of TCS.
      explanation: Confirms AR inheritance for biallelic POLR1C variants.
  notes: Encodes a subunit shared by RNA polymerases I and III. Biallelic mutations cause the autosomal recessive form of TCS.
  evidence:
  - reference: PMID:34573374
    reference_title: 'Treacher Collins Syndrome: Genetics, Clinical Features and Management.'
    supports: SUPPORT
    evidence_source: OTHER
    snippet: TCS can be caused by pathogenic variants in the TCOF1, POLR1D, POLR1C and POLR1B genes.
    explanation: Lists POLR1C as a causative gene for TCS.
- name: POLR1B
  relationship_type: CAUSATIVE
  presence: Present
  subtype: TCS4
  gene_term:
    preferred_term: POLR1B
    term:
      id: hgnc:20454
      label: POLR1B
  inheritance:
  - name: Autosomal dominant
    inheritance_term:
      preferred_term: Autosomal dominant inheritance
      term:
        id: HP:0000006
        label: Autosomal dominant inheritance
    evidence:
    - reference: PMID:20301704
      reference_title: Treacher Collins Syndrome.
      supports: SUPPORT
      evidence_source: OTHER
      snippet: less commonly heterozygous pathogenic variants in POLR1B or POLR1D
      explanation: Confirms AD inheritance for POLR1B variants.
  notes: Encodes the second largest subunit of RNA polymerase I. Heterozygous variants cause TCS4.
  evidence:
  - reference: PMID:20301704
    reference_title: Treacher Collins Syndrome.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: a heterozygous pathogenic variant in TCOF1, POLR1D, or POLR1B, biallelic pathogenic variants in POLR1C
    explanation: GeneReviews lists POLR1B as a TCS-causing gene.
treatments:
- name: Craniofacial Reconstruction
  description: >-
    Zygomatic, orbital, and mandibular reconstruction is planned by a
    multidisciplinary team and individualized to anatomy, function, severity,
    and likely reoperation burden. When breathing is not a concern, final
    orthognathic surgery is preferably deferred until skeletal maturity;
    earlier functional intervention may be required for airway, feeding,
    eyelid-closure, speech, or hearing problems.
  therapeutic_modality: SURGERY
  treatment_term:
    preferred_term: craniofacial surgical procedure
    term:
      id: NCIT:C15329
      label: Surgical Procedure
  evidence:
  - reference: PMID:20301704
    reference_title: Treacher Collins Syndrome.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: 'Craniofacial reconstruction is often necessary: zygomatic and orbital reconstruction at about age five to seven years, and bilateral microtia and/or narrow ear canal reconstruction after age six years.'
    explanation: GeneReviews supplies commonly used age windows, which are contextualized rather than treated as universal by the newer consensus.
  - reference: PMID:38801252
    reference_title: "Optimal Diagnostic and Treatment Practices for Facial Dysostosis Syndromes: A Clinical Consensus Statement Among European Experts."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      The optimal timing and sequence of craniofacial reconstruction procedures
      should be individualized based on the severity of the craniofacial
      anomalies and functional problems, including mouth opening, speech,
      feeding, (sleep related) breathing, closure of the eyelids, and hearing.
    explanation: European expert consensus makes severity and function, rather than age alone, the basis for sequencing reconstruction.
  - reference: PMID:38801252
    reference_title: "Optimal Diagnostic and Treatment Practices for Facial Dysostosis Syndromes: A Clinical Consensus Statement Among European Experts."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      However, in cases where breathing issues is not of concern, it is
      preferred to carry out (final) orthognathic surgery once the patient
      reaches skeletal maturity to avoid unnecessary reoperation.
    explanation: The consensus corrects the older unqualified pre-age-16 framing for final orthognathic surgery.
- name: Speech Therapy
  description: Speech and language therapy for developmental delay associated with conductive hearing impairment.
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: speech therapy
    term:
      id: NCIT:C159273
      label: Speech Language Therapy
  target_phenotypes:
  - preferred_term: Delayed speech and language development
    term:
      id: HP:0000750
      label: Delayed speech and language development
  evidence:
  - reference: PMID:20301704
    reference_title: Treacher Collins Syndrome.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: Hearing loss is treated with bone conduction amplification, speech therapy, and educational intervention.
    explanation: GeneReviews explicitly includes speech therapy within the multimodal approach to conductive hearing loss.
- name: Airway Management
  description: >-
    Airway care spans neonatal positioning, intubation or tracheostomy when
    required, routine obstructive-sleep-apnea screening with polysomnography,
    multilevel airway evaluation before intervention, and a documented
    perioperative difficult-airway plan. Intervention is individualized to the
    site and severity of obstruction.
  treatment_term:
    preferred_term: airway management
  target_phenotypes:
  - preferred_term: Upper airway obstruction
    term:
      id: HP:0002781
      label: Upper airway obstruction
  evidence:
  - reference: PMID:20301704
    reference_title: Treacher Collins Syndrome.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: Neonates with airway issues may require airway management at delivery, special positioning, or tracheostomy to facilitate ventilation.
    explanation: GeneReviews describes airway management strategies.
  - reference: PMID:40280475
    reference_title: Management and Outcomes of Neonates with Treacher Collins and Nager Syndromes.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Compared with infants with micrognathia, those with TCS were more likely
      to undergo tracheostomy (54% vs 11%) and gastrostomy tube placement (67%
      vs 35%) and were less likely to undergo mandibular distraction (9.7% vs
      28.2%).
    explanation: A 103-infant TCS NICU cohort quantifies major neonatal airway and feeding interventions; the selected NICU denominator is not a population frequency.
  - reference: PMID:37646339
    reference_title: Severity of Mandibular Dysmorphology in Treacher Collins Syndrome for Stratification of Perioperative Airway Risk.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      This study found a positive correlation between severity of
      maxillomandibular dysmorphology and perioperative airway difficulty in TCS
      patients.
    explanation: The 222-procedure cohort supports severity-stratified perioperative airway planning across the lifespan.
  - reference: PMID:38801252
    reference_title: "Optimal Diagnostic and Treatment Practices for Facial Dysostosis Syndromes: A Clinical Consensus Statement Among European Experts."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Polysomnography is currently the gold standard to screen for OSA (83), while
      questionnaires such as the Epworth Sleepiness Scale and the Brouillette
      score were not considered appropriate (85).
    explanation: The European consensus specifies objective OSA screening within longitudinal airway care.
- name: Enteral Tube Feeding
  description: >-
    Nasogastric or gastrostomy feeding can protect the airway and maintain
    caloric intake when mandibular, palatal, or swallowing abnormalities prevent
    safe and adequate oral feeding.
  therapeutic_modality: DEVICE
  treatment_term:
    preferred_term: Enteral Tube Feeding
    term:
      id: NCIT:C93322
      label: Enteral Tube Feeding
  target_phenotypes:
  - preferred_term: Feeding difficulties
    term:
      id: HP:0011968
      label: Feeding difficulties
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/books/NBK1532/
    reference_title: Treacher Collins Syndrome - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Assess nutrition and feeding support including nasogastric or gastrostomy
      tube feedings as needed to assure adequate caloric intake while protecting
      the airway
    explanation: GeneReviews recommends enteral feeding when oral intake is unsafe or inadequate.
  - reference: PMID:40280475
    reference_title: Management and Outcomes of Neonates with Treacher Collins and Nager Syndromes.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Compared with infants with micrognathia, those with TCS were more likely
      to undergo tracheostomy (54% vs 11%) and gastrostomy tube placement (67%
      vs 35%) and were less likely to undergo mandibular distraction (9.7% vs
      28.2%).
    explanation: The multicenter NICU cohort documents frequent gastrostomy use among critically affected neonates without generalizing 67% to all TCS.
- name: Cleft Palate Repair
  description: >-
    Cleft-palate repair is considered only after airway assessment. European
    consensus supports repair when obstructive AHI is 5 or lower without
    significant carbon-dioxide retention, or when polysomnography is normal,
    with high-care postoperative respiratory monitoring. Timing is
    individualized because reliable comparative timing and outcome evidence in
    facial dysostosis remains lacking.
  therapeutic_modality: SURGERY
  treatment_term:
    preferred_term: Palatorrhaphy
    term:
      id: NCIT:C168380
      label: Palatorrhaphy
  target_phenotypes:
  - preferred_term: Cleft palate
    term:
      id: HP:0000175
      label: Cleft palate
  evidence:
  - reference: PMID:38801252
    reference_title: "Optimal Diagnostic and Treatment Practices for Facial Dysostosis Syndromes: A Clinical Consensus Statement Among European Experts."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      If a cleft palate is (also) present, its repair can be considered if the
      obstructive apnea-hypopnea index (AHI) is ≤5 and there is no significant
      carbon dioxide retention or polysomnography results with or without a
      custom-made palatal plate are normal.
    explanation: The European consensus supplies the airway-safety qualification missing from an age-only repair recommendation.
  - reference: PMID:38801252
    reference_title: "Optimal Diagnostic and Treatment Practices for Facial Dysostosis Syndromes: A Clinical Consensus Statement Among European Experts."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Similarly, evidence on the relative effectiveness of different surgical
      approaches for palate repair in FDS patients, including different timing,
      is also lacking.
    explanation: This explicitly limits confidence in any universal age or technique.
- name: Hearing Amplification
  description: >-
    Audiology-directed amplification should start early. Air-conduction devices
    are the first choice when outer-ear anatomy permits and hearing and speech
    outcomes are acceptable; bone-conduction devices are an alternative for
    conductive or mixed loss from outer- or middle-ear malformation. Noninvasive
    versus implanted systems are individualized to anatomy, age, hearing loss,
    expected benefit, and patient preferences, and bone-conduction rehabilitation
    is preferred over reconstructive canal or middle-ear surgery when those
    surgical outcomes are expected to be poor.
  therapeutic_modality: DEVICE
  treatment_term:
    preferred_term: hearing amplification
  target_phenotypes:
  - preferred_term: Conductive hearing impairment
    term:
      id: HP:0000405
      label: Conductive hearing impairment
  evidence:
  - reference: PMID:38801252
    reference_title: "Optimal Diagnostic and Treatment Practices for Facial Dysostosis Syndromes: A Clinical Consensus Statement Among European Experts."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      the experts came to an agreement that air-conducting hearing devices are
      an appropriate first choice in FDS patients if acceptable hearing and
      speech intelligibility can be achieved, and their outer ear anatomy allows
      for wearing them
    explanation: The European consensus establishes the conditional first-line role of air-conduction amplification.
  - reference: PMID:38801252
    reference_title: "Optimal Diagnostic and Treatment Practices for Facial Dysostosis Syndromes: A Clinical Consensus Statement Among European Experts."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      For FDS patients with malformations of the middle and/or outer ears
      resulting in conductive or mixed hearing loss, bone-anchored or
      bone-conducting hearing devices are appropriate alternatives
    explanation: The consensus defines the anatomy and hearing-loss context in which bone-conduction devices are appropriate.
  - reference: PMID:38248782
    reference_title: "Systematic Review of Current Audiological Treatment Options for Patients with Treacher Collins Syndrome (TCS) and Surgical and Audiological Experiences of an Otorhinolaryngologist with TCS."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      In all other studies, it was evident that both conventional hearing aids
      and the various bone conduction devices improved auditory capacity by an
      average of about 30 dB.
    explanation: The 2024 systematic review summarizes objective improvement while noting small cohorts.
  - reference: PMID:38248782
    reference_title: "Systematic Review of Current Audiological Treatment Options for Patients with Treacher Collins Syndrome (TCS) and Surgical and Audiological Experiences of an Otorhinolaryngologist with TCS."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      However, due to the small amount of data, no general recommendations can
      be given for the treatment of hearing loss in TCS patients
    explanation: This limits the evidence to individualized device selection rather than a universal implant recommendation.
  - reference: PMID:41949491
    reference_title: Hearing rehabilitation in patients with Treacher Collins syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The unilateral BCHA implantation markedly improved the average sound
      field threshold from 62.00 ± 4.00 dB HL to 35.71 ± 4.99 dB HL with
      significant gains in SRT and SRS.
    explanation: The 2026 retrospective study documents objective benefit, while only seven of fourteen participants contributed aided follow-up measurements.
  - reference: PMID:38801252
    reference_title: "Optimal Diagnostic and Treatment Practices for Facial Dysostosis Syndromes: A Clinical Consensus Statement Among European Experts."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      bone-anchored or bone-conducting hearing aids are preferred over these
      types of reconstructive surgery for hearing rehabilitation
    explanation: The consensus favors amplification over reconstructive middle-ear or canal surgery given inconclusive surgical benefit.
- name: Periocular and Eyelid Reconstruction
  description: >-
    Perinatal ophthalmology assessment identifies vision risk from lower-eyelid
    coloboma, corneal exposure, refractive error, and strabismus. Lubrication is
    sufficient for many colobomas, but lesions threatening corneal integrity
    should be repaired in infancy; otherwise eyelid reconstruction is
    individualized to function and anatomy.
  therapeutic_modality: SURGERY
  treatment_term:
    preferred_term: Ophthalmologic Surgical Procedure
    term:
      id: NCIT:C15331
      label: Ophthalmologic Surgical Procedure
  target_phenotypes:
  - preferred_term: Lower eyelid coloboma
    term:
      id: HP:0000652
      label: Lower eyelid coloboma
  - preferred_term: Downslanted palpebral fissures
    term:
      id: HP:0000494
      label: Downslanted palpebral fissures
  evidence:
  - reference: PMID:38857421
    reference_title: Periorbital Outcomes and Vision Risk Stratification in Treacher Collins Syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Among 50 subjects, the mean follow-up was 10.5 ± 5.9 years. Periorbital
      findings included downslanting palpebral fissures (100%), eyelash
      deficiency (70%), eyelid coloboma (54%), and significant refractive error
      (50%).
    explanation: The modern pediatric cohort defines the clinical burden informing perinatal risk assessment.
  - reference: PMID:38857421
    reference_title: Periorbital Outcomes and Vision Risk Stratification in Treacher Collins Syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Alhough most eyelid colobomas can be managed with lubrication, those
      threatening corneal integrity should be repaired in infancy.
    explanation: This directly supports conservative management for most colobomas and early repair when the cornea is threatened; the misspelling is reproduced from the indexed abstract.
  - reference: PMID:38801252
    reference_title: "Optimal Diagnostic and Treatment Practices for Facial Dysostosis Syndromes: A Clinical Consensus Statement Among European Experts."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      in FDS patients with eyelid abnormalities without functional consequences,
      there is no critical timing for reconstructive eyelid surgery
    explanation: European consensus supports individualized timing when vision and corneal integrity are not threatened.
- name: Orthodontic Management
  description: >-
    Longitudinal orthodontic monitoring addresses growth and development of the
    dentition and jaws within lifelong multidisciplinary dental care.
  treatment_term:
    preferred_term: orthodontic management
  target_phenotypes:
  - preferred_term: Dental anomalies
    term:
      id: HP:0000164
      label: Abnormality of the dentition
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/books/NBK1532/
    reference_title: Treacher Collins Syndrome - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    snippet: Misaligned teeth often require orthodonture.
    explanation: GeneReviews explicitly recommends orthodonture for tooth misalignment.
  - reference: PMID:38801252
    reference_title: "Optimal Diagnostic and Treatment Practices for Facial Dysostosis Syndromes: A Clinical Consensus Statement Among European Experts."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      recommended that an orthodontist from the multidisciplinary team monitors
      the growth and development of the dentition and jaws
    explanation: European consensus defines the longitudinal developmental role of the orthodontist.
- name: Multidisciplinary Surveillance
  description: >-
    Surveillance includes early and longitudinal ophthalmology and audiology,
    routine obstructive-sleep-apnea screening with polysomnography when
    indicated, growth and feeding/aspiration assessment, dental review every six
    months with orthodontic follow-up, and periodic speech and educational
    assessment. Newly diagnosed patients also receive cardiac and vertebral
    screening because clinically important extracranial anomalies occur.
  treatment_term:
    preferred_term: Clinical Evaluation
    term:
      id: NCIT:C124351
      label: Clinical Evaluation
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/books/NBK1532/
    reference_title: Treacher Collins Syndrome - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Annual ophthalmology and audiology evaluations; assess for manifestations
      of obstructive sleep apnea, growth, and caloric intake at each visit;
      dental exams every six months with orthodontia exams as needed; assess
      speech development and educational progress annually or as needed.
    explanation: The current GeneReviews chapter supplies an interval-specific surveillance plan.
  - reference: PMID:38801252
    reference_title: "Optimal Diagnostic and Treatment Practices for Facial Dysostosis Syndromes: A Clinical Consensus Statement Among European Experts."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      The experts came to an agreement regarding the importance of
      ophthalmologic screening in newly diagnosed FDS patients to prevent
      secondary anomalies and vision impairment.
    explanation: European consensus supports ophthalmologic screening at diagnosis in addition to longitudinal review.
  - reference: PMID:38801252
    reference_title: "Optimal Diagnostic and Treatment Practices for Facial Dysostosis Syndromes: A Clinical Consensus Statement Among European Experts."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      the experts collectively expressed the necessity of audiological
      screening soon after birth to allow for timely treatment of hearing loss
      in FDS patients
    explanation: The consensus supplies the early-life audiology component.
  - reference: PMID:38801252
    reference_title: "Optimal Diagnostic and Treatment Practices for Facial Dysostosis Syndromes: A Clinical Consensus Statement Among European Experts."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      feeding problems also present a risk of aspiration and (near) fatal
      outcomes if left untreated. Therefore, the expert also reached consensus
      on the benefits of routine screening for feeding problems
    explanation: The consensus supports routine feeding and aspiration-risk screening.
  - reference: PMID:38801252
    reference_title: "Optimal Diagnostic and Treatment Practices for Facial Dysostosis Syndromes: A Clinical Consensus Statement Among European Experts."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      In newly diagnosed FDS patients, the experts considered a comprehensive
      screening for extracranial anomalies preferable, with special attention
      to vertebral and cardiac anomalies
    explanation: The consensus establishes initial cardiac and vertebral screening beyond craniofacial surveillance.
- name: Genetic Counseling
  action_category: COUNSELING_INFORMATIONAL
  description: >-
    Genetic counseling addresses dominant and recessive inheritance, de novo
    variation, recurrence risk including parental somatic or germline mosaicism,
    and prenatal or preimplantation testing. A molecular diagnosis can establish
    fetal status but cannot reliably predict individual severity.
  treatment_term:
    preferred_term: Genetic Counseling
    term:
      id: NCIT:C15240
      label: Genetic Counseling
  evidence:
  - reference: PMID:20301704
    reference_title: Treacher Collins Syndrome.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: Once the TCS-related pathogenic variant(s) have been identified in an affected family member, prenatal and preimplantation genetic testing are possible.
    explanation: GeneReviews describes genetic testing and counseling options.
  - reference: PMID:41857598
    reference_title: "Integrating imaging and genomics in prenatal Treacher Collins syndrome: evidence for practice and policy."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Prenatal diagnosis of TCS relies on ultrasound detection of craniofacial
      anomalies and gene testing, but severity prediction remains challenging
      due to mosaicism and variable expressivity. Low-level parental mosaicism
      materially affects recurrence-risk counselling and should be actively
      considered when a foetal variant appears de novo.
    explanation: The 2026 systematic review and two-family report supports the mosaicism and severity-prediction caveats in counseling.
diagnosis:
- name: Clinical diagnosis
  description: >-
    No consensus clinical diagnostic criteria have been published. A clinical
    diagnosis can be made from the characteristic bilaterally symmetric facial
    and mandibular abnormalities, downslanted palpebral fissures, zygomatic and
    mandibular hypoplasia, and conductive hearing loss. Limb anomalies,
    microcephaly, or intellectual disability are unusual and should trigger a
    broader differential diagnosis.
  diagnosis_term:
    preferred_term: Clinical Evaluation
    term:
      id: NCIT:C124351
      label: Clinical Evaluation
  results: A compatible symmetric craniofacial and conductive-hearing-loss pattern supports TCS but does not determine the causal gene.
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/books/NBK1532/
    reference_title: Treacher Collins Syndrome - GeneReviews® - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: OTHER
    snippet: No consensus clinical diagnostic criteria for Treacher Collins syndrome (TCS) have been published.
    explanation: The current GeneReviews chapter explicitly limits the status of formal clinical criteria.
  - reference: PMID:20301704
    reference_title: Treacher Collins Syndrome.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: Treacher Collins syndrome (TCS) is characterized by lower eyelid abnormalities, malar hypoplasia, downslanted palpebral fissures, and micro- or retrognathia due to symmetric hypoplasia of the zygomatic bones, maxilla, and mandible.
    explanation: GeneReviews describes the characteristic clinical pattern; it does not label it a consensus criterion set.
- name: Molecular genetic testing
  description: >-
    Use a craniofacial-disorder multigene panel with sequencing and
    deletion/duplication analysis, or exome/genome testing when the phenotype is
    atypical or panel testing is nondiagnostic. The molecular diagnosis is
    established by a heterozygous pathogenic variant in TCOF1, POLR1B, or
    POLR1D; biallelic pathogenic variants in POLR1C; or, rarely, biallelic
    pathogenic variants in POLR1D. A 5q deletion including TCOF1 is another
    uncommon mechanism. In unresolved cases with strong clinical suspicion,
    selected structural-variant, RNA, or long-read genomic analyses can reveal
    cryptic variants missed by routine short-read testing, but these remain
    complementary rather than first-line tests.
  diagnosis_term:
    preferred_term: genetic testing
    term:
      id: NCIT:C15709
      label: Genetic Testing
  results: Identification of a genotype matching one of the established dominant or recessive TCS mechanisms establishes the molecular diagnosis.
  evidence:
  - reference: PMID:20301704
    reference_title: Treacher Collins Syndrome.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: The diagnosis of TCS is established in a proband with characteristic clinical features and/or a heterozygous pathogenic variant in TCOF1, POLR1D, or POLR1B, biallelic pathogenic variants in POLR1C, or, rarely, biallelic pathogenic variants in POLR1D identified by molecular genetic testing.
    explanation: GeneReviews specifies the molecular diagnostic criteria for TCS.
  - reference: PMID:25790162
    reference_title: "Treacher Collins syndrome: a clinical and molecular study based on a large series of patients."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Among the atypical negative patients (with intellectual disability and/or
      microcephaly), we identified four patients carrying a mutation in EFTUD2
      and two patients with 5q32 deletion encompassing TCOF1 and CAMK2A in
      particular.
    explanation: The 146-person clinical/molecular series documents 5q32 deletions encompassing TCOF1 while also showing why additional features broaden the differential.
  - reference: PMID:38801252
    reference_title: "Optimal Diagnostic and Treatment Practices for Facial Dysostosis Syndromes: A Clinical Consensus Statement Among European Experts."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Overall, targeted genetic analyses are preferred in patients with a
      phenotype strongly suggesting a specific FDS, and broader genetic analyses
      (eg, whole exome or genome sequencing) in those with atypical phenotypes
      (113) and in those left without genetic confirmation with older genetic
      analyses.
    explanation: The European consensus supplies a complete, phenotype-stratified testing recommendation.
  - reference: PMID:41017149
    reference_title: Long-read DNA and RNA sequencing reveal an intronic retrotransposon insertion in TCOF1 causing Treacher Collins syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Long-read genome sequencing (lrGS) resolved a deep intronic 3.5 kb
      SINE-VNTR-Alu (SVA) retrotransposon insertion in intron 17 of TCOF1.
      Long-read RNA sequencing (lrRNA-seq) demonstrated that the insertion was
      partially exonized inducing isoform switch to the shorter non-canonical
      TCOF1 isoform c.
    explanation: This two-sibling study shows the selective diagnostic value of long-read DNA/RNA methods after conventional testing is unrevealing.
- name: Craniofacial and Temporal-Bone CT
  description: >-
    Craniofacial CT defines zygomatic and mandibular anatomy for surgical
    planning. In infants with conductive hearing loss, axial and coronal CT can
    assess the external canal, middle-ear ossicles and cavity, inner ear, head,
    and neck anatomy.
  diagnosis_term:
    preferred_term: Computed Tomography
    term:
      id: NCIT:C17204
      label: Computed Tomography
  results: Typical findings include zygomatic-arch hypoplasia or aplasia, mandibular retrognathia, canal atresia/stenosis, and middle-ear malformation.
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/books/NBK1532/pdf/Bookshelf_NBK1532.pdf
    reference_title: https://www.ncbi.nlm.nih.gov/books/NBK1532/pdf/Bookshelf_NBK1532.pdf
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      In those w/conductive hearing loss identified at age <6 mos:
      craniofacial CT scan (axial & coronal slices) to assess anatomy of head &
      neck, external auditory canal, middle ear, & inner ear
    explanation: GeneReviews Table 4 provides the complete age, indication, acquisition planes, and anatomic scope of the recommended CT evaluation.
  - reference: PMID:34573374
    reference_title: 'Treacher Collins Syndrome: Genetics, Clinical Features and Management.'
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Of significant importance is (computed tomography) CT scanning, used to
      document the anatomy of the head in order to prepare a plan for surgery,
      to recognize defects of hearing organs as well as to document progress in
      different stages of treatment
    explanation: This clinical review supports the craniofacial surgical-planning role and hearing-organ assessment.
differential_diagnoses:
- name: Nager Acrofacial Dysostosis
  disease_term:
    preferred_term: Nager acrofacial dysostosis
    term:
      id: MONDO:0007943
      label: Nager acrofacial dysostosis
  description: SF3B4-related Nager syndrome shares mandibulofacial dysostosis, micrognathia, and downslanted palpebral fissures.
  distinguishing_features:
  - Preaxial radial-ray abnormalities such as hypoplastic or absent thumbs, triphalangeal thumbs, radial hypoplasia/aplasia, or radioulnar synostosis favor Nager syndrome; limb anomalies are rare in TCS.
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/books/NBK1532/pdf/Bookshelf_NBK1532.pdf
    reference_title: https://www.ncbi.nlm.nih.gov/books/NBK1532/pdf/Bookshelf_NBK1532.pdf
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      SF3B4 Acrofacial dysostosis, SF3B4-related (Nager syndrome) (OMIM 154400)
      AD Downslanted palpebral fissures Micrognathia Mandibulofacial dysostosis
      Limb deformities Preaxial abnormalities (e.g., small or absent thumbs,
      triphalangeal thumbs, radial hypoplasia or aplasia, radioulnar synostosis)
    explanation: The GeneReviews differential table explicitly associates the preaxial limb pattern with SF3B4-related Nager syndrome.
- name: Miller Syndrome
  disease_term:
    preferred_term: postaxial acrofacial dysostosis
    term:
      id: MONDO:0009903
      label: postaxial acrofacial dysostosis
  description: DHODH-related Miller syndrome overlaps through mandibulofacial dysostosis, eyelid coloboma, micrognathia, and cleft lip/palate.
  distinguishing_features:
  - Postaxial limb abnormalities, especially small or absent fifth digits/metacarpals, ulnar hypoplasia, or absent fifth toes, favor Miller syndrome.
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/books/NBK1532/pdf/Bookshelf_NBK1532.pdf
    reference_title: https://www.ncbi.nlm.nih.gov/books/NBK1532/pdf/Bookshelf_NBK1532.pdf
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      DHODH Postaxial acrofacial dysostosis, DHODH-related (Miller syndrome)
      (OMIM 263750) AR Mandibulofacial dysostosis Eyelid coloboma Micrognathia
      Cleft lip/palate Limb deformities Postaxial abnormalities (e.g., small or
      absent 5th digit incl 5th metacarpal, ulnar hypoplasia, absent 5th toe)
    explanation: The GeneReviews differential table explicitly associates the postaxial limb pattern with DHODH-related Miller syndrome, bound here to the exact MONDO postaxial acrofacial dysostosis concept.
- name: Mandibulofacial Dysostosis with Microcephaly
  disease_term:
    preferred_term: Mandibulofacial dysostosis with microcephaly
    term:
      id: MONDO:0012516
      label: mandibulofacial dysostosis-microcephaly syndrome
  description: EFTUD2-related disease shares mandibulofacial dysostosis, microtia, preauricular tags, cleft palate, and airway involvement.
  distinguishing_features:
  - Congenital or progressive microcephaly and intellectual disability are typical, whereas intellect is usually normal in TCS.
  - Facial asymmetry, esophageal atresia/tracheoesophageal fistula, and thumb abnormalities further favor EFTUD2-related disease.
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/books/NBK1532/pdf/Bookshelf_NBK1532.pdf
    reference_title: https://www.ncbi.nlm.nih.gov/books/NBK1532/pdf/Bookshelf_NBK1532.pdf
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      EFTUD2 Mandibulofacial dysostosis w/ microcephaly, EFTUD2-related
      (Guion-Almeida type) AD Mandibulofacial dysostosis Microtia Preauricular
      skin tags Microcephaly is present in most affected persons. Intellectual
      disability Asymmetry of facial features
    explanation: The GeneReviews differential table explicitly links microcephaly, intellectual disability, and asymmetry to EFTUD2-related mandibulofacial dysostosis.
- name: Craniofacial Microsomia
  disease_term:
    preferred_term: Craniofacial microsomia
    term:
      id: MONDO:0015397
      label: craniofacial microsomia
  description: Craniofacial microsomia can share mandibular/maxillary hypoplasia, microtia, ear-canal atresia, preauricular tags, and clefting.
  distinguishing_features:
  - Craniofacial microsomia is usually unilateral or bilaterally asymmetric rather than the characteristic bilateral symmetry of TCS.
  - Epibulbar dermoids and vertebral anomalies, including Klippel-Feil anomaly, favor the craniofacial microsomia/Goldenhar spectrum.
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/books/NBK1532/pdf/Bookshelf_NBK1532.pdf
    reference_title: https://www.ncbi.nlm.nih.gov/books/NBK1532/pdf/Bookshelf_NBK1532.pdf
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      FOXI3 1 SF3B2 2 Hemifacial microsomia (Goldenhar syndrome,
      Oculo- auriculo-vertebral spectrum) (OMIM PS164210) AD AR Mandibulofacial
      dysostosis Microtia Preauricular skin tags Cleft lip/palate Asymmetric
      Ocular epibulbar dermoid cyst Vertebral anomalies, Klippel-Feil anomaly
    explanation: The GeneReviews differential table explicitly links asymmetry, epibulbar dermoid, and vertebral anomalies to hemifacial microsomia.
- name: POLR1A-Related Acrofacial Dysostosis, Cincinnati Type
  disease_term:
    preferred_term: acrofacial dysostosis Cincinnati type
    term:
      id: MONDO:0014651
      label: acrofacial dysostosis Cincinnati type
  description: >-
    This RNA-polymerase-I-related disorder shares mandibulofacial dysostosis,
    micrognathia, eyelid coloboma, clefting, and microtia, but it is not a fifth
    TCS subtype and POLR1A is not curated as a TCS gene.
  distinguishing_features:
  - Neurodevelopmental abnormalities, congenital heart defects, and limb defects are substantially more common than in TCS.
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/books/NBK1532/pdf/Bookshelf_NBK1532.pdf
    reference_title: https://www.ncbi.nlm.nih.gov/books/NBK1532/pdf/Bookshelf_NBK1532.pdf
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      POLR1A 3 Mandibulofacial dysostosis w/ limb deficiencies, POLR1A-related
      (Cincinnati type) (OMIM 616462) AD Mandibulofacial dysostosis Micrognathia
      Eyelid coloboma Cleft lip/palate Microtia/anotia Abnormal neurodevelopment
      in ~78% (e.g., abnormal muscle tone, developmental delay, epilepsy)
      Congenital heart defects in ~44% (e.g., septal defects) Limb defects in
      ~33% (e.g., bowed long bones)
    explanation: The GeneReviews differential table explicitly separates POLR1A-related Cincinnati-type disease by its neurodevelopmental, cardiac, and limb burden.
animal_models:
- species: Mus musculus
  genotype: Tcof1 haploinsufficient (Tcof1+/-)
  genes:
  - preferred_term: TCOF1
    term:
      id: hgnc:11654
      label: TCOF1
  associated_phenotypes:
  - Deficient generation and proliferation of migrating cranial neural crest cells
  - Bilateral craniofacial skeletal hypoplasia with perinatal respiratory compromise on susceptible backgrounds
  description: >-
    Germline Tcof1 haploinsufficiency is the foundational TCS model. It reproduces
    deficient mature-ribosome production, p53-dependent neuroepithelial/neural
    crest apoptosis, neural crest deficiency, and craniofacial hypoplasia.
    Phenotypic severity depends strongly on strain background, and rescue by p53
    inhibition or maternal antioxidants is prenatal animal-model evidence rather
    than an established human intervention.
  evidence:
  - reference: PMID:16938878
    reference_title: Tcof1/Treacle is required for neural crest cell formation and proliferation deficiencies that cause craniofacial abnormalities.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: To investigate the developmental basis of TCS we generated a mouse model through germ-line mutation of Tcof1.
    explanation: The primary study defines the germline Tcof1 model and its developmental purpose.
  - reference: PMID:18246078
    reference_title: Prevention of the neurocristopathy Treacher Collins syndrome through inhibition of p53 function.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      inhibition of p53 prevents cyclin G1-driven apoptotic elimination of
      neural crest cells while rescuing the craniofacial abnormalities associated
      with mutations in Tcof1 and extending life span.
    explanation: The rescue experiment validates the p53-dependent component of the mouse model.
  - reference: PMID:26792133
    reference_title: Prevention of Treacher Collins syndrome craniofacial anomalies in mouse models via maternal antioxidant supplementation.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      maternal treatment with antioxidants minimizes cell death in the
      neuroepithelium and substantially ameliorates or prevents the pathogenesis
      of craniofacial anomalies in Tcof1(+/-) mice.
    explanation: A distinct prenatal rescue supports the oxidative-stress arm in this genotype.
- species: Danio rerio
  genotype: polr1c-deficient TCS3 morpholino model
  genes:
  - preferred_term: POLR1C
    term:
      id: hgnc:20194
      label: POLR1C
  associated_phenotypes:
  - Abnormal migrated cranial neural crest distribution in the pharyngeal arches
  - Ethmoid plate craniofacial cartilage deformity
  description: >-
    Transient polr1c deficiency models TCS3 with excess facial-region reactive
    oxygen species, p53-dependent apoptosis, altered neural crest distribution,
    and craniofacial cartilage deformity. Morpholino transience and zebrafish
    anatomy limit direct fidelity to biallelic human POLR1C disease.
  evidence:
  - reference: PMID:38556235
    reference_title: p53 inhibitor or antioxidants reduce the severity of ethmoid plate deformities in zebrafish Type 3 Treacher Collins syndrome model.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      the restoration of polr1c expression in early embryogenesis effectively
      rescues the observed craniofacial phenotype in polr1c-deficient zebrafish.
    explanation: Genetic rescue supports specificity of the polr1c-deficient phenotype.
experimental_models:
- name: TCOF1-Haploinsufficient Human Pluripotent Stem Cell-Derived Neural Crest Model
  experimental_model_type: OTHER
  organism:
    preferred_term: human
    term:
      id: NCBITaxon:9606
      label: Homo sapiens
  cell_types:
  - preferred_term: Migratory cranial neural crest cell
    term:
      id: CL:0000008
      label: migratory cranial neural crest cell
  cell_source: CRISPR/Cas9-engineered TCOF1+/- human pluripotent stem cell lines and separate siRNA TCOF1-knockdown cultures
  culture_system: Chemically defined neural crest differentiation followed by serial-passage purification and migration assays
  publication: PMID:30375284
  description: >-
    This human developmental cell model complements the mouse studies by
    reproducing neural crest phenotypes in TCOF1-haploinsufficient cells. It
    captures cell-autonomous migration and survival behavior but not pharyngeal
    arch anatomy, tissue interactions, or the full craniofacial phenotype.
  modeled_mechanisms:
  - target: Cranial Neural Crest Cell Deficiency
    description: TCOF1+/- neural crest and mesenchymal derivatives show impaired migration in vitro.
    evidence:
    - reference: PMID:30375284
      reference_title: A Novel Human Pluripotent Stem Cell-Derived Neural Crest Model of Treacher Collins Syndrome Shows Defects in Cell Death and Migration.
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: We also report for the first time an impairment of migration in TCOF1+/- NC and mesenchymal stem cells.
      explanation: The modeled mechanism is directly measured in the engineered human cells.
  findings:
  - statement: TCOF1+/- human neural crest cells recapitulate the abnormal cell-death phenotype of the murine TCS model and add a migration deficit.
    supporting_text: >-
      The NC cells derived from TCOF1+/- HPSC recapitulate the phenotype of the
      reported TCS murine model. We also report for the first time an impairment
      of migration in TCOF1+/- NC and mesenchymal stem cells.
    evidence:
    - reference: PMID:30375284
      reference_title: A Novel Human Pluripotent Stem Cell-Derived Neural Crest Model of Treacher Collins Syndrome Shows Defects in Cell Death and Migration.
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: >-
        The NC cells derived from TCOF1+/- HPSC recapitulate the phenotype of
        the reported TCS murine model. We also report for the first time an
        impairment of migration in TCOF1+/- NC and mesenchymal stem cells.
      explanation: The finding is stated directly in the model paper.
  evidence:
  - reference: PMID:30375284
    reference_title: A Novel Human Pluripotent Stem Cell-Derived Neural Crest Model of Treacher Collins Syndrome Shows Defects in Cell Death and Migration.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      We assessed the potential of the derived NC population to model the
      neurocristopathy, Treacher Collins Syndrome (TCS), using small interfering
      RNA (siRNA) knockdown of TCOF1 and by creating different TCOF1+/- HPSC
      lines through CRISPR/Cas9 technology.
    explanation: The primary study describes both perturbation strategies used to construct the human model.
datasets:
- accession: geo:GSE10167
  title: Microarray Analysis of Treacher Collins Syndrome
  description: >-
    Whole-embryo expression profiling of three E8.5 Tcof1+/- mouse embryos and
    three wild-type littermates, generated to identify transcriptional changes
    associated with Tcof1 haploinsufficiency.
  organism:
    preferred_term: mouse
    term:
      id: NCBITaxon:10090
      label: Mus musculus
  data_type: MICROARRAY
  sample_count: 6
  conditions:
  - E8.5 Tcof1+/- littermate embryo
  - E8.5 wild-type littermate embryo
  platform: Affymetrix GeneChip Mouse Genome 430 2.0 array (GPL1261)
  publication: PMID:18246078
  genes:
  - preferred_term: TCOF1
    term:
      id: hgnc:11654
      label: TCOF1
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE10167
    reference_title: GEO Accession viewer
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Total RNA was extracted from 3 E8.5 wild-type and 3 E8.5 Tcof1+/-
      littermate embryos
    explanation: The GEO record verifies the genotype groups, developmental stage, and sample count.
  notes: >-
    Direct disease-model dataset linked to the p53-rescue study. Because RNA is
    from whole embryos rather than isolated cranial neural crest, cell-type
    specificity cannot be inferred directly from this dataset alone.
- accession: geo:GSE89420
  title: Surveillance of rRNA synthesis by an RNA helicase mediates tissue-specific developmental disorders
  description: >-
    Ten human HeLa samples profiling DDX21/TCOF1 chromatin occupancy and DDX21
    RNA binding under TCOF1 knockdown, RNA polymerase I inhibition, or
    actinomycin D treatment.
  organism:
    preferred_term: human
    term:
      id: NCBITaxon:9606
      label: Homo sapiens
  data_type: MULTI_OMICS_PERTURBATION
  sample_count: 10
  conditions:
  - siTCOF1 and control HeLa chromatin profiling
  - RNA polymerase I inhibition and control
  - actinomycin D and DMSO DDX21 irCLIP
  platform: ChIP-seq and DDX21 irCLIP
  publication: PMID:29364875
  genes:
  - preferred_term: TCOF1
    term:
      id: hgnc:11654
      label: TCOF1
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE89420
    reference_title: GEO Accession viewer
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: HeLa DDX21 ChIP-seq in siTCOF1
    explanation: The GEO record verifies the TCOF1-knockdown DDX21 chromatin-profiling sample in HeLa cells.
  - reference: url:https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE89420
    reference_title: GEO Accession viewer
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: HeLa DDX21 ChIP-seq in iPol I treated cells
    explanation: The GEO sample list independently verifies the RNA-polymerase-I-inhibition chromatin-profiling arm.
  - reference: url:https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE89420
    reference_title: GEO Accession viewer
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: DDX21 irCLIP from HeLa with ActD Biological replicate 1
    explanation: The GEO sample list verifies the DDX21 RNA-binding arm under actinomycin-D treatment in HeLa cells.
  notes: >-
    Mechanistically relevant but not a patient-derived or cranial-neural-crest
    dataset: all deposited samples are HeLa perturbation experiments. It can
    support TCOF1/DDX21 nucleolar-stress analysis but cannot establish a
    disease-specific human craniofacial expression signature. Gene-only cancer
    datasets returned by discovery were excluded.
discussions:
- discussion_id: prenatal_stress_rescue_translation_gap
  kind: HUMAN_MODEL_MISMATCH
  status: OPEN
  prompt: >-
    Can prenatal reduction of p53 signaling or oxidative stress prevent human
    TCS malformations without unacceptable developmental, oncogenic, or
    pregnancy risk?
  attaches_to:
  - pathophysiology#TCOF1-Associated Oxidative DNA Damage
  - pathophysiology#p53-Dependent Neuroepithelial Apoptosis
  rationale: >-
    Genetic/pharmacologic p53 inhibition and maternal antioxidant treatment can
    rescue Tcof1+/- mice, and both strategies improve the polr1c-deficient
    zebrafish phenotype within a narrow embryonic window. The target window in
    humans precedes or overlaps common recognition of pregnancy, and systemic
    p53 inhibition interferes with a tumor-suppressor and DNA-damage response.
    Antioxidant identity, dose, tissue delivery, genotype coverage, and fetal
    safety are unresolved. These interventions therefore remain mechanistic
    animal-model probes, not clinical treatments.
  evidence:
  - reference: PMID:18246078
    reference_title: Prevention of the neurocristopathy Treacher Collins syndrome through inhibition of p53 function.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      suppression of p53 function provides an attractive avenue for possible
      clinical prevention of TCS craniofacial birth defects
    explanation: The source itself frames p53 suppression as a possible future avenue rather than established treatment.
  - reference: PMID:26792133
    reference_title: Prevention of Treacher Collins syndrome craniofacial anomalies in mouse models via maternal antioxidant supplementation.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      maternal antioxidant dietary supplementation may provide an avenue for
      protection against the pathogenesis of TCS and similar neurocristopathies.
    explanation: The antioxidant strategy is similarly prospective and based on a prenatal mouse rescue.
  - reference: PMID:38556235
    reference_title: p53 inhibitor or antioxidants reduce the severity of ethmoid plate deformities in zebrafish Type 3 Treacher Collins syndrome model.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      inhibiting p53 activation or applying antioxidants within a specific time
      window, notably within 30 h post-fertilization (hpf), successfully reversed
      phenotypic effects induced by polr1c MO.
    explanation: The TCS3 model emphasizes the narrow developmental timing and nonhuman evidence boundary.
- discussion_id: genotype_phenotype_correlation_interpretation
  kind: INTERPRETATION
  status: OPEN
  prompt: >-
    Which reported gene-, exon-, and variant-class associations are robust
    enough to inform prognosis in an individual with TCS?
  rationale: >-
    A deeply phenotyped 146-person cohort found no phenotype-genotype
    correlation across TCOF1/POLR1D, variant type, or TCOF1 localization, while
    a later systematic review reported statistical gene/ancestry and recurrent
    exon-24 deletion associations. Differences in ascertainment, severity
    scoring, missing data, family clustering, and small non-TCOF1 sample sizes
    could explain the discrepancy. The entry therefore records variable
    expressivity but does not use genotype to predict an individual's severity.
  evidence:
  - reference: PMID:25790162
    reference_title: "Treacher Collins syndrome: a clinical and molecular study based on a large series of patients."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Even though TCOF1 and POLR1D were associated with extreme clinical
      variability, we found no phenotype-genotype correlation.
    explanation: The 146-person clinical/molecular cohort reports a negative correlation result.
  - reference: PMID:36203321
    reference_title: "A systematic review on Treacher Collins syndrome: Correlation between molecular genetic findings and clinical severity."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Our result suggested that the higher severity level was likely to be
      observed in Asian patients harboring TCOF1 variants rather than POLR1.
    explanation: The later systematic review reports a positive association that requires cautious interpretation.
  - reference: PMID:36203321
    reference_title: "A systematic review on Treacher Collins syndrome: Correlation between molecular genetic findings and clinical severity."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Moreover, common 5-bp deletions tended to have a higher severity degree
      in comparison to any variants within exon 24 of TCOF1.
    explanation: The systematic review also reports a variant-class association that has not yet established individual prognostic utility.
- discussion_id: emerging_diagnostic_adjuncts_and_generalizability
  kind: INTERPRETATION
  status: OPEN
  prompt: >-
    How should long-read DNA/RNA sequencing, prenatal imaging, and facial-image
    algorithms be incorporated into TCS diagnosis without overextending small,
    selected, or ancestry-imbalanced datasets?
  attaches_to:
  - diagnosis#Clinical diagnosis
  - diagnosis#Molecular genetic testing
  - treatments#Genetic Counseling
  rationale: >-
    Long-read multi-omics resolved a cryptic intronic TCOF1 insertion in two
    paternal half-siblings after conventional testing, establishing value for
    selected unresolved families rather than first-line use. Prenatal imaging
    plus molecular testing can identify affected fetuses, but mosaicism and
    variable expressivity prevent reliable severity prediction. A 2026 facial
    dysmorphology study reported high sensitivity on 127 publicly available
    images but lower confidence in Asian than White participants; it remains a
    research adjunct and cannot replace clinical evaluation or molecular
    confirmation.
  evidence:
  - reference: PMID:41017149
    reference_title: Long-read DNA and RNA sequencing reveal an intronic retrotransposon insertion in TCOF1 causing Treacher Collins syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Here, we describe two previously undiagnosed paternal half-siblings
      affected with clinical TCS, and their apparently unaffected father.
      Diagnostic short-read RNA sequencing) identified aberrant expression of
      TCOF1 and optical genome mapping detected a large genomic insertion
      therein.
    explanation: The family demonstrates diagnostic value after a long unresolved workup but is too small to establish a general first-line strategy.
  - reference: PMID:41857598
    reference_title: "Integrating imaging and genomics in prenatal Treacher Collins syndrome: evidence for practice and policy."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Prenatal diagnosis of TCS relies on ultrasound detection of craniofacial
      anomalies and gene testing, but severity prediction remains challenging
      due to mosaicism and variable expressivity.
    explanation: The systematic review supports prenatal diagnosis while defining its prognostic limit.
  - reference: PMID:41817050
    reference_title: Evaluation of a Facial Dysmorphology Analysis Algorithm (Face2Gene) in Identifying Treacher Collins Syndrome Amongst Diverse Population.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      A total of 127 images of TCS patients were analysed by F2G. A high
      diagnostic accuracy of 93.7% was obtained. However, F2G was less confident
      when diagnosing Asians with TCS than White individuals (p < 0.05).
    explanation: Performance on selected public images is promising, while the ancestry-dependent confidence and image-source design limit clinical generalization.
- discussion_id: multisystem_and_neonatal_ascertainment
  kind: INTERPRETATION
  status: OPEN
  prompt: >-
    Which multisystem associations and neonatal intervention rates should alter
    routine care, and which reflect EHR coding or tertiary-NICU ascertainment?
  attaches_to:
  - phenotypes#Upper Airway Obstruction
  - phenotypes#Feeding Difficulties
  - treatments#Airway Management
  - treatments#Multidisciplinary Surveillance
  rationale: >-
    A propensity-matched EHR study of 1,114 coded TCS patients found elevated
    circulatory, otologic, and selected neurologic diagnoses, while a 103-infant
    multicenter NICU cohort quantified high tracheostomy and gastrostomy use.
    These studies broaden multisystem and neonatal outcome ascertainment, but
    neither supplies population penetrance: coding validity and phenotype/genotype
    resolution constrain the EHR analysis, and NICU referral enriches for severe
    neonatal disease. The 2024 European consensus therefore supports initial
    cardiac/vertebral screening and structured feeding, hearing, vision, and
    airway surveillance without encoding the cohort estimates as universal
    phenotype frequencies.
  evidence:
  - reference: PMID:37415506
    reference_title: "Treacher Collins Syndrome Associated with Disproportionate Nervous System, Cardiovascular, Otologic Complications Among 1,114 Patients."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Patients with TCS (n = 1,114) and a propensity matched control cohort
      without TCS (n = 1,114 matched from n = 110,368,585).
    explanation: The national-scale EHR design supplies a large matched comparison but depends on coded diagnoses rather than uniformly confirmed molecular TCS.
  - reference: PMID:37415506
    reference_title: "Treacher Collins Syndrome Associated with Disproportionate Nervous System, Cardiovascular, Otologic Complications Among 1,114 Patients."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The RR of congenital malformations of the circulatory system in patients
      with TCS was 8.5 (95% CI 4.44-16.28). Patients with TCS also had higher
      rates of otologic abnormalities including conductive hearing loss (RR 44,
      95% CI 24-83) and nervous system disorders including movement disorders
      (RR 2.60, 95% CI 1.27-5.50) and recurrent seizures (RR 4.2, 95% CI
      2.12-8.33).
    explanation: The study identifies associations requiring prospective, molecularly resolved validation before causal or penetrance claims.
  - reference: PMID:40280475
    reference_title: Management and Outcomes of Neonates with Treacher Collins and Nager Syndromes.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We identified 103 infants with TCS and 11 with NS to compare with the
      micrognathia cohort (n = 4210). Compared with infants with micrognathia,
      those with TCS were more likely to undergo tracheostomy (54% vs 11%) and
      gastrostomy tube placement (67% vs 35%) and were less likely to undergo
      mandibular distraction (9.7% vs 28.2%).
    explanation: The cohort materially informs severe neonatal planning, but admission to participating NICUs selects for high-acuity infants.
  - reference: PMID:38801252
    reference_title: "Optimal Diagnostic and Treatment Practices for Facial Dysostosis Syndromes: A Clinical Consensus Statement Among European Experts."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      In newly diagnosed FDS patients, the experts considered a comprehensive
      screening for extracranial anomalies preferable, with special attention
      to vertebral and cardiac anomalies
    explanation: The European consensus converts the multisystem concern into a bounded initial-screening recommendation rather than a universal disease-frequency assertion.
references:
- reference: PMID:20301704
  title: Treacher Collins Syndrome.
  tags:
  - GeneReviews
- reference: url:https://www.ncbi.nlm.nih.gov/books/NBK1532/
  title: Treacher Collins Syndrome - GeneReviews® - NCBI Bookshelf
  tags:
  - GeneReviews
- reference: url:https://www.ncbi.nlm.nih.gov/books/NBK1532/pdf/Bookshelf_NBK1532.pdf
  title: https://www.ncbi.nlm.nih.gov/books/NBK1532/pdf/Bookshelf_NBK1532.pdf
  tags:
  - GeneReviews
- reference: PMID:16938878
  title: Tcof1/Treacle is required for neural crest cell formation and proliferation deficiencies that cause craniofacial abnormalities.
- reference: PMID:18246078
  title: Prevention of the neurocristopathy Treacher Collins syndrome through inhibition of p53 function.
- reference: PMID:24690222
  title: "Treacher Collins Syndrome: the genetics of a craniofacial disease."
- reference: PMID:25790162
  title: "Treacher Collins syndrome: a clinical and molecular study based on a large series of patients."
- reference: PMID:26792133
  title: Prevention of Treacher Collins syndrome craniofacial anomalies in mouse models via maternal antioxidant supplementation.
- reference: PMID:27448281
  title: The Roles of RNA Polymerase I and III Subunits Polr1c and Polr1d in Craniofacial Development and in Zebrafish Models of Treacher Collins Syndrome.
- reference: PMID:29364875
  title: Tissue-selective effects of nucleolar stress and rDNA damage in developmental disorders.
- reference: PMID:30375284
  title: A Novel Human Pluripotent Stem Cell-Derived Neural Crest Model of Treacher Collins Syndrome Shows Defects in Cell Death and Migration.
- reference: PMID:31649276
  title: POLR1B and neural crest cell anomalies in Treacher Collins syndrome type 4.
- reference: PMID:33804586
  title: "The Role of TCOF1 Gene in Health and Disease: Beyond Treacher Collins Syndrome."
- reference: PMID:34573374
  title: "Treacher Collins Syndrome: Genetics, Clinical Features and Management."
- reference: PMID:35032653
  title: "Ocular and adnexal anomalies in Treacher Collins syndrome: a retrospective multicenter study."
- reference: PMID:36203321
  title: "A systematic review on Treacher Collins syndrome: Correlation between molecular genetic findings and clinical severity."
- reference: PMID:36779427
  title: "Nosology of genetic skeletal disorders: 2023 revision."
- reference: PMID:37415506
  title: "Treacher Collins Syndrome Associated with Disproportionate Nervous System, Cardiovascular, Otologic Complications Among 1,114 Patients."
- reference: PMID:37646339
  title: Severity of Mandibular Dysmorphology in Treacher Collins Syndrome for Stratification of Perioperative Airway Risk.
- reference: PMID:38248782
  title: "Systematic Review of Current Audiological Treatment Options for Patients with Treacher Collins Syndrome (TCS) and Surgical and Audiological Experiences of an Otorhinolaryngologist with TCS."
- reference: PMID:38556235
  title: p53 inhibitor or antioxidants reduce the severity of ethmoid plate deformities in zebrafish Type 3 Treacher Collins syndrome model.
- reference: PMID:38801252
  title: "Optimal Diagnostic and Treatment Practices for Facial Dysostosis Syndromes: A Clinical Consensus Statement Among European Experts."
- reference: PMID:38857421
  title: Periorbital Outcomes and Vision Risk Stratification in Treacher Collins Syndrome.
- reference: PMID:39920764
  title: "Deciphering TCOF1 mutations in Chinese Treacher Collins syndrome patients: insights into pathogenesis and transcriptional disruption."
- reference: PMID:40280475
  title: Management and Outcomes of Neonates with Treacher Collins and Nager Syndromes.
- reference: PMID:41017149
  title: Long-read DNA and RNA sequencing reveal an intronic retrotransposon insertion in TCOF1 causing Treacher Collins syndrome.
- reference: PMID:41817050
  title: Evaluation of a Facial Dysmorphology Analysis Algorithm (Face2Gene) in Identifying Treacher Collins Syndrome Amongst Diverse Population.
- reference: PMID:41857598
  title: "Integrating imaging and genomics in prenatal Treacher Collins syndrome: evidence for practice and policy."
- reference: PMID:41949491
  title: Hearing rehabilitation in patients with Treacher Collins syndrome.
- reference: url:https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE10167
  title: GEO Accession viewer
- reference: url:https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE89420
  title: GEO Accession viewer
review_notes: >-
  Identity and lump/split boundary: this entry represents the MONDO:0002457
  Treacher Collins syndrome umbrella and retains the four MONDO-backed subtypes
  TCS1-TCS4. The causal gene set is TCOF1, POLR1B, POLR1C, and POLR1D;
  heterozygous POLR1D causes dominant TCS2 and rare biallelic POLR1D variants
  cause recessive TCS. POLR1A-related acrofacial dysostosis (Cincinnati type) is
  a close ribosomopathy differential, not a TCS subtype or fifth TCS gene.

  The mechanism graph is atomized into ribosome-biogenesis failure, a
  TCOF1-specific oxidative DNA-damage-response arm, p53-dependent apoptosis,
  cranial neural crest deficiency, and serial arch-derivative maldevelopment.
  The trigger, intermediate, and tissue-consequence nodes conform to the three
  corresponding nodes of the pharyngeal-arch serial-homology module. All four
  causal genes are wired at the proximal node; the neural crest migration GO
  term is confined to the cell-population node rather than the skeletal output.

  The 2024 GeneReviews chapter was mined across clinical characteristics,
  diagnosis/testing, management/surveillance, and genetic counseling. No formal
  clinical diagnostic criteria or evidence-graded TCS clinical practice
  guideline has been published; however, the 2024 ERN CRANIO Delphi clinical
  consensus statement (PMID:38801252; 92 experts and three patient
  representatives) now provides multidisciplinary diagnostic and treatment
  consensus and is incorporated throughout this entry.

  Current-literature review through 2026-08-17 incorporated the 1,114-person
  matched EHR study (PMID:37415506), the 222-procedure perioperative-airway
  cohort (PMID:37646339), the 103-infant NICU cohort (PMID:40280475), the
  50-person periorbital cohort (PMID:38857421), 2026 hearing-rehabilitation data
  (PMID:41949491), and emerging long-read, prenatal-genomic, and facial-image
  diagnostic studies (PMID:41017149, PMID:41857598, PMID:41817050). Selection,
  coding, sample-size, and ancestry-generalizability limits are recorded rather
  than converting those estimates into population penetrance or standard-of-care
  diagnostic claims. No disease-modifying human intervention or TCS-specific
  therapeutic trial was identified; prenatal p53 inhibition and antioxidant
  rescue remain animal experiments with a structured translation mismatch.

  Dataset discovery was triaged rather than copied wholesale. GSE10167 is a
  direct Tcof1+/- embryo dataset. GSE89420 is a mechanistically relevant
  TCOF1/DDX21 HeLa perturbation dataset and is explicitly not disease-derived
  cranial neural crest data. Both accessions were verified through the
  repository workflow; gene-only cancer hits and generic neural crest datasets
  were excluded. Published birth-frequency estimates differ (1:50,000 versus
  1:80,000), and reported genotype-phenotype correlations remain inconsistent,
  so neither is presented with false precision.
📚

References & Deep Research

References

31
Treacher Collins Syndrome.
No top-level findings curated for this source.
Treacher Collins Syndrome - GeneReviews® - NCBI Bookshelf
No top-level findings curated for this source.
https://www.ncbi.nlm.nih.gov/books/NBK1532/pdf/Bookshelf_NBK1532.pdf
No top-level findings curated for this source.
Tcof1/Treacle is required for neural crest cell formation and proliferation deficiencies that cause craniofacial abnormalities.
No top-level findings curated for this source.
Prevention of the neurocristopathy Treacher Collins syndrome through inhibition of p53 function.
No top-level findings curated for this source.
Treacher Collins Syndrome: the genetics of a craniofacial disease.
No top-level findings curated for this source.
Treacher Collins syndrome: a clinical and molecular study based on a large series of patients.
No top-level findings curated for this source.
Prevention of Treacher Collins syndrome craniofacial anomalies in mouse models via maternal antioxidant supplementation.
No top-level findings curated for this source.
The Roles of RNA Polymerase I and III Subunits Polr1c and Polr1d in Craniofacial Development and in Zebrafish Models of Treacher Collins Syndrome.
No top-level findings curated for this source.
Tissue-selective effects of nucleolar stress and rDNA damage in developmental disorders.
No top-level findings curated for this source.
A Novel Human Pluripotent Stem Cell-Derived Neural Crest Model of Treacher Collins Syndrome Shows Defects in Cell Death and Migration.
No top-level findings curated for this source.
POLR1B and neural crest cell anomalies in Treacher Collins syndrome type 4.
No top-level findings curated for this source.
The Role of TCOF1 Gene in Health and Disease: Beyond Treacher Collins Syndrome.
No top-level findings curated for this source.
Treacher Collins Syndrome: Genetics, Clinical Features and Management.
No top-level findings curated for this source.
Ocular and adnexal anomalies in Treacher Collins syndrome: a retrospective multicenter study.
No top-level findings curated for this source.
A systematic review on Treacher Collins syndrome: Correlation between molecular genetic findings and clinical severity.
No top-level findings curated for this source.
Nosology of genetic skeletal disorders: 2023 revision.
No top-level findings curated for this source.
Treacher Collins Syndrome Associated with Disproportionate Nervous System, Cardiovascular, Otologic Complications Among 1,114 Patients.
No top-level findings curated for this source.
Severity of Mandibular Dysmorphology in Treacher Collins Syndrome for Stratification of Perioperative Airway Risk.
No top-level findings curated for this source.
Systematic Review of Current Audiological Treatment Options for Patients with Treacher Collins Syndrome (TCS) and Surgical and Audiological Experiences of an Otorhinolaryngologist with TCS.
No top-level findings curated for this source.
p53 inhibitor or antioxidants reduce the severity of ethmoid plate deformities in zebrafish Type 3 Treacher Collins syndrome model.
No top-level findings curated for this source.
Optimal Diagnostic and Treatment Practices for Facial Dysostosis Syndromes: A Clinical Consensus Statement Among European Experts.
No top-level findings curated for this source.
Periorbital Outcomes and Vision Risk Stratification in Treacher Collins Syndrome.
No top-level findings curated for this source.
Deciphering TCOF1 mutations in Chinese Treacher Collins syndrome patients: insights into pathogenesis and transcriptional disruption.
No top-level findings curated for this source.
Management and Outcomes of Neonates with Treacher Collins and Nager Syndromes.
No top-level findings curated for this source.
Long-read DNA and RNA sequencing reveal an intronic retrotransposon insertion in TCOF1 causing Treacher Collins syndrome.
No top-level findings curated for this source.
Evaluation of a Facial Dysmorphology Analysis Algorithm (Face2Gene) in Identifying Treacher Collins Syndrome Amongst Diverse Population.
No top-level findings curated for this source.
Integrating imaging and genomics in prenatal Treacher Collins syndrome: evidence for practice and policy.
No top-level findings curated for this source.
Hearing rehabilitation in patients with Treacher Collins syndrome.
No top-level findings curated for this source.
No top-level findings curated for this source.
No top-level findings curated for this source.

Deep Research

1
Treacher Collins Syndrome - Manual PubMed Research

Treacher Collins Syndrome - Manual PubMed Research

Research Method

Manual literature search via PubMed E-utilities API (no deep research API keys available).

Key References

  1. PMID:20301704 - Barbosa M, Jabs EW, Huston S (2024 update). GeneReviews: Treacher Collins Syndrome.
  2. Comprehensive clinical review covering clinical characteristics, genetics, management, and genetic counseling.
  3. Key source for clinical features, diagnostic criteria, and management guidelines.

  4. PMID:34573374 - Marszałek-Kruk BA et al. (2021). Treacher Collins Syndrome: Genetics, Clinical Features and Management.

  5. Review covering genetics, phenotype, and surgical management.
  6. Source for prevalence (1 in 50,000) and four subtypes.

  7. PMID:33804586 - Grzanka M, Piekiełko-Witkowska A (2021). The Role of TCOF1 Gene in Health and Disease.

  8. Full-text review of TCOF1/Treacle function in ribosome biogenesis.
  9. Key source for molecular pathophysiology.

  10. PMID:24690222 - Kadakia S et al. (2014). Treacher Collins Syndrome: the genetics of a craniofacial disease.

  11. Review of genetics and pathophysiology.
  12. Key source for ribosome biogenesis → p53-dependent apoptosis mechanism.

Key Facts

  • MONDO:0002457
  • Incidence: ~1 in 50,000 live births
  • Inheritance: Autosomal dominant (TCOF1, POLR1B, POLR1D) or autosomal recessive (POLR1C, POLR1D biallelic)
  • 55-61% of AD cases are de novo
  • TCOF1 mutations account for >90% of cases
  • Pathomechanism: Impaired ribosome biogenesis → p53-dependent neural crest cell apoptosis → craniofacial skeletal hypoplasia
  • Core features: Malar hypoplasia, micrognathia, downslanted palpebral fissures, lower eyelid coloboma, microtia, conductive hearing loss
  • Intellect typically normal